{
  "doc_id": "23",
  "paragraphs": [
    {
      "paragraph_id": "0",
      "paragraph": "预混胰岛素临床应用专家共识(2016年版)",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "预混胰岛素临床应用专家共识(2016年版)",
          "start_idx": 0,
          "end_idx": 21,
          "entities": [
            {
              "entity_id": "T0",
              "entity": "预混胰岛素",
              "entity_type": "Drug",
              "start_idx": 0,
              "end_idx": 5
            }
          ],
          "relations": []
        }
      ]
    },
    {
      "paragraph_id": "1",
      "paragraph": "2007~2008年中国糖尿病流行病学调查结果显示，我国20岁以上的人群中糖尿病的患病率为9.7%，而2010年的调查数据显示，我国成人糖尿病患病率高达11.6%。中国糖尿病患者人数已经位居全球首位，并且给社会和家庭带来沉重的经济负担。中国新诊断的2型糖尿病(type 2 diabetesmellius，T2DM)患者以餐后血糖升高为主，这可能与中国患者胰岛β细胞功能的衰退更显著、饮食结构多以碳水化合物为主有关。预混胰岛素能同时提供基础和餐时胰岛素，控制餐后血糖同时兼顾整体血糖。因此，目前多数中国T2DM患者选择预混胰岛素为胰岛素起始治疗方案。",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "2007~2008年中国糖尿病流行病学调查结果显示，我国20岁以上的人群中糖尿病的患病率为9.7%，而2010年的调查数据显示，我国成人糖尿病患病率高达11.6%。中国糖尿病患者人数已经位居全球首位，并且给社会和家庭带来沉重的经济负担。中国新诊断的2型糖尿病(type 2 diabetesmellius，T2DM)患者以餐后血糖升高为主，这可能与中国患者胰岛β细胞功能的衰退更显著、饮食结构多以碳水化合物为主有关。预混胰岛素能同时提供基础和餐时胰岛素，控制餐后血糖同时兼顾整体血糖。因此，目前多数中国T2DM患者选择预混胰岛素为胰岛素起始治疗方案。",
          "start_idx": 0,
          "end_idx": 275,
          "entities": [
            {
              "entity_id": "T1",
              "entity": "糖尿病",
              "entity_type": "Disease",
              "start_idx": 12,
              "end_idx": 15
            },
            {
              "entity_id": "T2",
              "entity": "糖尿病",
              "entity_type": "Disease",
              "start_idx": 37,
              "end_idx": 40
            },
            {
              "entity_id": "T3",
              "entity": "糖尿病",
              "entity_type": "Disease",
              "start_idx": 68,
              "end_idx": 71
            },
            {
              "entity_id": "T4",
              "entity": "糖尿病",
              "entity_type": "Disease",
              "start_idx": 84,
              "end_idx": 87
            },
            {
              "entity_id": "T5",
              "entity": "2型糖尿病(type 2 diabetesmellius，T2DM)",
              "entity_type": "Disease",
              "start_idx": 124,
              "end_idx": 158
            },
            {
              "entity_id": "T6",
              "entity": "2型",
              "entity_type": "Class",
              "start_idx": 124,
              "end_idx": 126
            },
            {
              "entity_id": "T7",
              "entity": "餐后血糖",
              "entity_type": "Test_items",
              "start_idx": 161,
              "end_idx": 165
            },
            {
              "entity_id": "T8",
              "entity": "升高",
              "entity_type": "Test_Value",
              "start_idx": 165,
              "end_idx": 167
            },
            {
              "entity_id": "T9",
              "entity": "胰岛β细胞功能的衰退",
              "entity_type": "Pathogenesis",
              "start_idx": 178,
              "end_idx": 188
            },
            {
              "entity_id": "T10",
              "entity": "饮食结构多以碳水化合物为主",
              "entity_type": "Reason",
              "start_idx": 192,
              "end_idx": 205
            },
            {
              "entity_id": "T11",
              "entity": "预混胰岛素",
              "entity_type": "Drug",
              "start_idx": 208,
              "end_idx": 213
            },
            {
              "entity_id": "T12",
              "entity": "餐后血糖",
              "entity_type": "Test_items",
              "start_idx": 229,
              "end_idx": 233
            },
            {
              "entity_id": "T13",
              "entity": "血糖",
              "entity_type": "Test_items",
              "start_idx": 239,
              "end_idx": 241
            },
            {
              "entity_id": "T14",
              "entity": "T2DM",
              "entity_type": "Disease",
              "start_idx": 251,
              "end_idx": 255
            },
            {
              "entity_id": "T15",
              "entity": "T2",
              "entity_type": "Class",
              "start_idx": 251,
              "end_idx": 253
            },
            {
              "entity_id": "T16",
              "entity": "预混胰岛素",
              "entity_type": "Drug",
              "start_idx": 259,
              "end_idx": 264
            },
            {
              "entity_id": "T17",
              "entity": "胰岛素",
              "entity_type": "Drug",
              "start_idx": 265,
              "end_idx": 268
            },
            {
              "entity_id": "T18",
              "entity": "胰岛素",
              "entity_type": "Drug",
              "start_idx": 223,
              "end_idx": 226
            }
          ],
          "relations": [
            {
              "relation_type": "Class_Disease",
              "relation_id": "R0",
              "head_entity_id": "T6",
              "tail_entity_id": "T5"
            },
            {
              "relation_type": "Test_items_Disease",
              "relation_id": "R1",
              "head_entity_id": "T7",
              "tail_entity_id": "T5"
            },
            {
              "relation_type": "Pathogenesis_Disease",
              "relation_id": "R2",
              "head_entity_id": "T9",
              "tail_entity_id": "T5"
            },
            {
              "relation_type": "Reason_Disease",
              "relation_id": "R3",
              "head_entity_id": "T10",
              "tail_entity_id": "T5"
            },
            {
              "relation_type": "Class_Disease",
              "relation_id": "R4",
              "head_entity_id": "T15",
              "tail_entity_id": "T14"
            },
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R5",
              "head_entity_id": "T16",
              "tail_entity_id": "T14"
            },
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R6",
              "head_entity_id": "T17",
              "tail_entity_id": "T14"
            }
          ]
        }
      ]
    },
    {
      "paragraph_id": "2",
      "paragraph": "尽管接受口服药物治疗及生活方式干预，但大部分T2DM患者胰岛β细胞功能仍随病程进展逐渐恶化，故及时启动胰岛素治疗能减轻胰岛β细胞负荷，解除高糖毒性，改善胰岛素抵抗，保护残存的β细胞功能。《中国2型糖尿病防治指南(2013年版)》指出，每日1次基础胰岛素或每日1~2次预混胰岛素均可作为胰岛素起始治疗方案，如基础胰岛素或预混胰岛素与口服降糖药联合治疗控制血糖不达标则应将治疗方案调整为多次胰岛素注射(基础+餐时胰岛素或每日3次预混胰岛素类似物)。",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "尽管接受口服药物治疗及生活方式干预，但大部分T2DM患者胰岛β细胞功能仍随病程进展逐渐恶化，故及时启动胰岛素治疗能减轻胰岛β细胞负荷，解除高糖毒性，改善胰岛素抵抗，保护残存的β细胞功能。《中国2型糖尿病防治指南(2013年版)》指出，每日1次基础胰岛素或每日1~2次预混胰岛素均可作为胰岛素起始治疗方案，如基础胰岛素或预混胰岛素与口服降糖药联合治疗控制血糖不达标则应将治疗方案调整为多次胰岛素注射(基础+餐时胰岛素或每日3次预混胰岛素类似物)。",
          "start_idx": 0,
          "end_idx": 222,
          "entities": [
            {
              "entity_id": "T19",
              "entity": "生活方式干预",
              "entity_type": "Treatment",
              "start_idx": 11,
              "end_idx": 17
            },
            {
              "entity_id": "T20",
              "entity": "T2DM",
              "entity_type": "Disease",
              "start_idx": 22,
              "end_idx": 26
            },
            {
              "entity_id": "T21",
              "entity": "T2",
              "entity_type": "Class",
              "start_idx": 22,
              "end_idx": 24
            },
            {
              "entity_id": "T22",
              "entity": "胰岛β细胞功能仍随病程进展逐渐恶化",
              "entity_type": "Pathogenesis",
              "start_idx": 28,
              "end_idx": 45
            },
            {
              "entity_id": "T23",
              "entity": "胰岛素",
              "entity_type": "Drug",
              "start_idx": 51,
              "end_idx": 54
            },
            {
              "entity_id": "T24",
              "entity": "胰岛β细胞负荷",
              "entity_type": "Pathogenesis",
              "start_idx": 59,
              "end_idx": 66
            },
            {
              "entity_id": "T25",
              "entity": "胰岛素抵抗",
              "entity_type": "Pathogenesis",
              "start_idx": 76,
              "end_idx": 81
            },
            {
              "entity_id": "T26",
              "entity": "2型糖尿病",
              "entity_type": "Disease",
              "start_idx": 96,
              "end_idx": 101
            },
            {
              "entity_id": "T27",
              "entity": "2型",
              "entity_type": "Class",
              "start_idx": 96,
              "end_idx": 98
            },
            {
              "entity_id": "T28",
              "entity": "每日1次",
              "entity_type": "Frequency",
              "start_idx": 117,
              "end_idx": 121
            },
            {
              "entity_id": "T29",
              "entity": "胰岛素",
              "entity_type": "Drug",
              "start_idx": 123,
              "end_idx": 126
            },
            {
              "entity_id": "T30",
              "entity": "每日1~2次",
              "entity_type": "Frequency",
              "start_idx": 127,
              "end_idx": 133
            },
            {
              "entity_id": "T31",
              "entity": "预混胰岛素",
              "entity_type": "Drug",
              "start_idx": 133,
              "end_idx": 138
            },
            {
              "entity_id": "T32",
              "entity": "胰岛素",
              "entity_type": "Drug",
              "start_idx": 142,
              "end_idx": 145
            },
            {
              "entity_id": "T33",
              "entity": "胰岛素",
              "entity_type": "Drug",
              "start_idx": 155,
              "end_idx": 158
            },
            {
              "entity_id": "T34",
              "entity": "预混胰岛素",
              "entity_type": "Drug",
              "start_idx": 159,
              "end_idx": 164
            },
            {
              "entity_id": "T35",
              "entity": "血糖",
              "entity_type": "Test_items",
              "start_idx": 176,
              "end_idx": 178
            },
            {
              "entity_id": "T36",
              "entity": "不达标",
              "entity_type": "Test_Value",
              "start_idx": 178,
              "end_idx": 181
            },
            {
              "entity_id": "T37",
              "entity": "胰岛素",
              "entity_type": "Drug",
              "start_idx": 193,
              "end_idx": 196
            },
            {
              "entity_id": "T38",
              "entity": "注射",
              "entity_type": "Method",
              "start_idx": 196,
              "end_idx": 198
            },
            {
              "entity_id": "T39",
              "entity": "胰岛素",
              "entity_type": "Drug",
              "start_idx": 204,
              "end_idx": 207
            },
            {
              "entity_id": "T40",
              "entity": "每日3次",
              "entity_type": "Frequency",
              "start_idx": 208,
              "end_idx": 212
            },
            {
              "entity_id": "T41",
              "entity": "预混胰岛素类似物",
              "entity_type": "Drug",
              "start_idx": 212,
              "end_idx": 220
            },
            {
              "entity_id": "T42",
              "entity": "口服",
              "entity_type": "Method",
              "start_idx": 4,
              "end_idx": 6
            },
            {
              "entity_id": "T43",
              "entity": "口服",
              "entity_type": "Method",
              "start_idx": 165,
              "end_idx": 167
            }
          ],
          "relations": [
            {
              "relation_type": "Treatment_Disease",
              "relation_id": "R7",
              "head_entity_id": "T19",
              "tail_entity_id": "T20"
            },
            {
              "relation_type": "Class_Disease",
              "relation_id": "R8",
              "head_entity_id": "T21",
              "tail_entity_id": "T20"
            },
            {
              "relation_type": "Pathogenesis_Disease",
              "relation_id": "R9",
              "head_entity_id": "T22",
              "tail_entity_id": "T20"
            },
            {
              "relation_type": "Pathogenesis_Disease",
              "relation_id": "R10",
              "head_entity_id": "T24",
              "tail_entity_id": "T20"
            },
            {
              "relation_type": "Pathogenesis_Disease",
              "relation_id": "R11",
              "head_entity_id": "T25",
              "tail_entity_id": "T20"
            },
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R12",
              "head_entity_id": "T23",
              "tail_entity_id": "T20"
            },
            {
              "relation_type": "Class_Disease",
              "relation_id": "R13",
              "head_entity_id": "T27",
              "tail_entity_id": "T26"
            },
            {
              "relation_type": "Frequency_Drug",
              "relation_id": "R14",
              "head_entity_id": "T28",
              "tail_entity_id": "T29"
            },
            {
              "relation_type": "Frequency_Drug",
              "relation_id": "R15",
              "head_entity_id": "T30",
              "tail_entity_id": "T31"
            },
            {
              "relation_type": "Method_Drug",
              "relation_id": "R16",
              "head_entity_id": "T38",
              "tail_entity_id": "T37"
            },
            {
              "relation_type": "Frequency_Drug",
              "relation_id": "R17",
              "head_entity_id": "T40",
              "tail_entity_id": "T41"
            }
          ]
        }
      ]
    },
    {
      "paragraph_id": "3",
      "paragraph": "为了更好地指导临床医生合理规范使用预混胰岛素，中华医学会内分泌学分会(Chinese Society of Endocrinology，CSE)于2013年发表了《预混胰岛素临床应用共识》，考虑到三年来有一些临床研究证据的更新，故基于原共识进行重新修订。",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "为了更好地指导临床医生合理规范使用预混胰岛素，中华医学会内分泌学分会(Chinese Society of Endocrinology，CSE)于2013年发表了《预混胰岛素临床应用共识》，考虑到三年来有一些临床研究证据的更新，故基于原共识进行重新修订。",
          "start_idx": 0,
          "end_idx": 127,
          "entities": [
            {
              "entity_id": "T44",
              "entity": "预混胰岛素",
              "entity_type": "Drug",
              "start_idx": 17,
              "end_idx": 22
            },
            {
              "entity_id": "T45",
              "entity": "预混胰岛素",
              "entity_type": "Drug",
              "start_idx": 82,
              "end_idx": 87
            }
          ],
          "relations": []
        }
      ]
    },
    {
      "paragraph_id": "4",
      "paragraph": "1 预混胰岛素分类",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "1 预混胰岛素分类",
          "start_idx": 0,
          "end_idx": 9,
          "entities": [
            {
              "entity_id": "T46",
              "entity": "预混胰岛素",
              "entity_type": "Drug",
              "start_idx": 2,
              "end_idx": 7
            }
          ],
          "relations": []
        }
      ]
    },
    {
      "paragraph_id": "5",
      "paragraph": "预混胰岛素主要包括预混人胰岛素和预混胰素类似物(见表1)。",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "预混胰岛素主要包括预混人胰岛素和预混胰素类似物(见表1)。",
          "start_idx": 0,
          "end_idx": 29,
          "entities": [
            {
              "entity_id": "T47",
              "entity": "预混胰岛素",
              "entity_type": "Drug",
              "start_idx": 0,
              "end_idx": 5
            },
            {
              "entity_id": "T48",
              "entity": "预混人胰岛素",
              "entity_type": "Drug",
              "start_idx": 9,
              "end_idx": 15
            },
            {
              "entity_id": "T49",
              "entity": "预混胰素类似物",
              "entity_type": "Drug",
              "start_idx": 16,
              "end_idx": 23
            }
          ],
          "relations": []
        }
      ]
    },
    {
      "paragraph_id": "6",
      "paragraph": "1.1 预混人胰岛素预混人胰岛素是指将重组人胰岛素(短效)与精蛋白锌重组人胰岛素(中效)按一定比例混合而成的胰岛素制剂，包括低预混人胰岛素和中预混人胰岛素。",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "1.1 预混人胰岛素预混人胰岛素是指将重组人胰岛素(短效)与精蛋白锌重组人胰岛素(中效)按一定比例混合而成的胰岛素制剂，包括低预混人胰岛素和中预混人胰岛素。",
          "start_idx": 0,
          "end_idx": 78,
          "entities": [
            {
              "entity_id": "T50",
              "entity": "预混人胰岛素",
              "entity_type": "Drug",
              "start_idx": 4,
              "end_idx": 10
            },
            {
              "entity_id": "T51",
              "entity": "预混人胰岛素",
              "entity_type": "Drug",
              "start_idx": 10,
              "end_idx": 16
            },
            {
              "entity_id": "T52",
              "entity": "重组人胰岛素(短效)",
              "entity_type": "Drug",
              "start_idx": 19,
              "end_idx": 29
            },
            {
              "entity_id": "T53",
              "entity": "精蛋白锌重组人胰岛素(中效)",
              "entity_type": "Drug",
              "start_idx": 30,
              "end_idx": 44
            },
            {
              "entity_id": "T54",
              "entity": "胰岛素制剂",
              "entity_type": "Drug",
              "start_idx": 54,
              "end_idx": 59
            },
            {
              "entity_id": "T55",
              "entity": "预混人胰岛素",
              "entity_type": "Drug",
              "start_idx": 63,
              "end_idx": 69
            },
            {
              "entity_id": "T56",
              "entity": "预混人胰岛素",
              "entity_type": "Drug",
              "start_idx": 71,
              "end_idx": 77
            }
          ],
          "relations": []
        }
      ]
    },
    {
      "paragraph_id": "7",
      "paragraph": "低预混人胰岛素主要为70/30剂型(30%短效+70%中效)，如优泌林70/30、诺和灵30R、甘舒霖30R、重和林M30等。",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "低预混人胰岛素主要为70/30剂型(30%短效+70%中效)，如优泌林70/30、诺和灵30R、甘舒霖30R、重和林M30等。",
          "start_idx": 0,
          "end_idx": 63,
          "entities": [
            {
              "entity_id": "T57",
              "entity": "优泌林",
              "entity_type": "Drug",
              "start_idx": 32,
              "end_idx": 35
            },
            {
              "entity_id": "T58",
              "entity": "诺和灵",
              "entity_type": "Drug",
              "start_idx": 41,
              "end_idx": 44
            },
            {
              "entity_id": "T59",
              "entity": "甘舒霖",
              "entity_type": "Drug",
              "start_idx": 48,
              "end_idx": 51
            },
            {
              "entity_id": "T60",
              "entity": "重和林",
              "entity_type": "Drug",
              "start_idx": 55,
              "end_idx": 58
            },
            {
              "entity_id": "T61",
              "entity": "预混人胰岛素",
              "entity_type": "Drug",
              "start_idx": 1,
              "end_idx": 7
            }
          ],
          "relations": []
        }
      ]
    },
    {
      "paragraph_id": "8",
      "paragraph": "中预混人胰岛素主要为50/50剂型(50%短效+50%中效)，如诺和灵50R、甘舒霖50R等。",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "中预混人胰岛素主要为50/50剂型(50%短效+50%中效)，如诺和灵50R、甘舒霖50R等。",
          "start_idx": 0,
          "end_idx": 47,
          "entities": [
            {
              "entity_id": "T62",
              "entity": "预混人胰岛素",
              "entity_type": "Drug",
              "start_idx": 1,
              "end_idx": 7
            },
            {
              "entity_id": "T63",
              "entity": "诺和灵",
              "entity_type": "Drug",
              "start_idx": 32,
              "end_idx": 35
            },
            {
              "entity_id": "T64",
              "entity": "甘舒霖",
              "entity_type": "Drug",
              "start_idx": 39,
              "end_idx": 42
            }
          ],
          "relations": []
        }
      ]
    },
    {
      "paragraph_id": "9",
      "paragraph": "1.2 预混胰岛素类似物预混胰岛素类似物是指将速效胰岛素类似物(赖脯胰岛素或门冬胰岛素)与精蛋白锌速效胰岛素类似物按一定比例混合而成的胰岛素制剂，包括低预混胰岛素类似物和中预混胰岛素类似物。",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "1.2 预混胰岛素类似物预混胰岛素类似物是指将速效胰岛素类似物(赖脯胰岛素或门冬胰岛素)与精蛋白锌速效胰岛素类似物按一定比例混合而成的胰岛素制剂，包括低预混胰岛素类似物和中预混胰岛素类似物。",
          "start_idx": 0,
          "end_idx": 95,
          "entities": [
            {
              "entity_id": "T65",
              "entity": "预混胰岛素类似物",
              "entity_type": "Drug",
              "start_idx": 4,
              "end_idx": 12
            },
            {
              "entity_id": "T66",
              "entity": "预混胰岛素类似物",
              "entity_type": "Drug",
              "start_idx": 12,
              "end_idx": 20
            },
            {
              "entity_id": "T67",
              "entity": "速效胰岛素类似物",
              "entity_type": "Drug",
              "start_idx": 23,
              "end_idx": 31
            },
            {
              "entity_id": "T68",
              "entity": "赖脯胰岛素",
              "entity_type": "Drug",
              "start_idx": 32,
              "end_idx": 37
            },
            {
              "entity_id": "T69",
              "entity": "门冬胰岛素",
              "entity_type": "Drug",
              "start_idx": 38,
              "end_idx": 43
            },
            {
              "entity_id": "T70",
              "entity": "精蛋白锌速效胰岛素类似物",
              "entity_type": "Drug",
              "start_idx": 45,
              "end_idx": 57
            },
            {
              "entity_id": "T71",
              "entity": "胰岛素制剂",
              "entity_type": "Drug",
              "start_idx": 67,
              "end_idx": 72
            },
            {
              "entity_id": "T72",
              "entity": "预混胰岛素类似物",
              "entity_type": "Drug",
              "start_idx": 76,
              "end_idx": 84
            },
            {
              "entity_id": "T73",
              "entity": "预混胰岛素类似物",
              "entity_type": "Drug",
              "start_idx": 86,
              "end_idx": 94
            }
          ],
          "relations": []
        }
      ]
    },
    {
      "paragraph_id": "10",
      "paragraph": "国内低预混胰岛素类似物主要为75/25剂型，如赖脯胰岛素25(25%赖脯胰岛素+75%精蛋白锌赖脯胰岛素)和70/30剂型，如门冬胰岛素30(30%门冬胰岛素+70%精蛋白锌门冬胰岛素)。",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "国内低预混胰岛素类似物主要为75/25剂型，如赖脯胰岛素25(25%赖脯胰岛素+75%精蛋白锌赖脯胰岛素)和70/30剂型，如门冬胰岛素30(30%门冬胰岛素+70%精蛋白锌门冬胰岛素)。",
          "start_idx": 0,
          "end_idx": 94,
          "entities": [
            {
              "entity_id": "T74",
              "entity": "预混胰岛素类似物",
              "entity_type": "Drug",
              "start_idx": 3,
              "end_idx": 11
            },
            {
              "entity_id": "T75",
              "entity": "赖脯胰岛素",
              "entity_type": "Drug",
              "start_idx": 23,
              "end_idx": 28
            },
            {
              "entity_id": "T76",
              "entity": "赖脯胰岛素",
              "entity_type": "Drug",
              "start_idx": 34,
              "end_idx": 39
            },
            {
              "entity_id": "T77",
              "entity": "精蛋白锌赖脯胰岛素",
              "entity_type": "Drug",
              "start_idx": 43,
              "end_idx": 52
            },
            {
              "entity_id": "T78",
              "entity": "门冬胰岛素",
              "entity_type": "Drug",
              "start_idx": 63,
              "end_idx": 68
            },
            {
              "entity_id": "T79",
              "entity": "门冬胰岛素",
              "entity_type": "Drug",
              "start_idx": 74,
              "end_idx": 79
            },
            {
              "entity_id": "T80",
              "entity": "精蛋白锌门冬胰岛素",
              "entity_type": "Drug",
              "start_idx": 83,
              "end_idx": 92
            }
          ],
          "relations": []
        }
      ]
    },
    {
      "paragraph_id": "11",
      "paragraph": "中预混胰岛素类似物主要为50/50剂型，如赖脯胰岛素50(50%赖脯胰岛素+50%精蛋白锌赖脯胰岛素)和门冬胰岛素50(50%门冬胰岛素+50%精蛋白锌门冬胰岛素)。",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "中预混胰岛素类似物主要为50/50剂型，如赖脯胰岛素50(50%赖脯胰岛素+50%精蛋白锌赖脯胰岛素)和门冬胰岛素50(50%门冬胰岛素+50%精蛋白锌门冬胰岛素)。",
          "start_idx": 0,
          "end_idx": 83,
          "entities": [
            {
              "entity_id": "T81",
              "entity": "预混胰岛素类似物",
              "entity_type": "Drug",
              "start_idx": 1,
              "end_idx": 9
            },
            {
              "entity_id": "T82",
              "entity": "赖脯胰岛素",
              "entity_type": "Drug",
              "start_idx": 21,
              "end_idx": 26
            },
            {
              "entity_id": "T83",
              "entity": "赖脯胰岛素",
              "entity_type": "Drug",
              "start_idx": 32,
              "end_idx": 37
            },
            {
              "entity_id": "T84",
              "entity": "精蛋白锌赖脯胰岛素",
              "entity_type": "Drug",
              "start_idx": 41,
              "end_idx": 50
            },
            {
              "entity_id": "T85",
              "entity": "门冬胰岛素",
              "entity_type": "Drug",
              "start_idx": 52,
              "end_idx": 57
            },
            {
              "entity_id": "T86",
              "entity": "门冬胰岛素",
              "entity_type": "Drug",
              "start_idx": 63,
              "end_idx": 68
            },
            {
              "entity_id": "T87",
              "entity": "精蛋白锌门冬胰岛素",
              "entity_type": "Drug",
              "start_idx": 72,
              "end_idx": 81
            }
          ],
          "relations": []
        }
      ]
    },
    {
      "paragraph_id": "12",
      "paragraph": "2 预混胰岛素治疗方案",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "2 预混胰岛素治疗方案",
          "start_idx": 0,
          "end_idx": 11,
          "entities": [
            {
              "entity_id": "T88",
              "entity": "预混胰岛素",
              "entity_type": "Drug",
              "start_idx": 2,
              "end_idx": 7
            }
          ],
          "relations": []
        }
      ]
    },
    {
      "paragraph_id": "13",
      "paragraph": "2.1 每日1次方案",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "2.1 每日1次方案",
          "start_idx": 0,
          "end_idx": 10,
          "entities": [
            {
              "entity_id": "T89",
              "entity": "每日1次",
              "entity_type": "Frequency",
              "start_idx": 4,
              "end_idx": 8
            }
          ],
          "relations": []
        }
      ]
    },
    {
      "paragraph_id": "14",
      "paragraph": "2.1.1 适用人群生活方式干预及两种或两种以上口服降糖药最大有效剂量治疗后HbA1c≥7.0%的患者。2.1.2 预混胰岛素选择低预混人胰岛素、低预混胰素类似物、中预混人胰岛素、中预混胰岛素类似物。2.1.3 起始剂量每日1次起始剂量一般为0.2IU/(kg·d)，",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "2.1.1 适用人群生活方式干预及两种或两种以上口服降糖药最大有效剂量治疗后HbA1c≥7.0%的患者。",
          "start_idx": 0,
          "end_idx": 52,
          "entities": [
            {
              "entity_id": "T90",
              "entity": "生活方式干预",
              "entity_type": "Treatment",
              "start_idx": 10,
              "end_idx": 16
            },
            {
              "entity_id": "T91",
              "entity": "口服",
              "entity_type": "Method",
              "start_idx": 24,
              "end_idx": 26
            },
            {
              "entity_id": "T92",
              "entity": "HbA1c",
              "entity_type": "Test_items",
              "start_idx": 38,
              "end_idx": 43
            },
            {
              "entity_id": "T93",
              "entity": "≥7.0%",
              "entity_type": "Test_Value",
              "start_idx": 43,
              "end_idx": 48
            }
          ],
          "relations": []
        },
        {
          "sentence_id": "1",
          "sentence": "2.1.2 预混胰岛素选择低预混人胰岛素、低预混胰素类似物、中预混人胰岛素、中预混胰岛素类似物。",
          "start_idx": 52,
          "end_idx": 100,
          "entities": [
            {
              "entity_id": "T94",
              "entity": "预混胰岛素",
              "entity_type": "Drug",
              "start_idx": 6,
              "end_idx": 11
            },
            {
              "entity_id": "T95",
              "entity": "预混人胰岛素",
              "entity_type": "Drug",
              "start_idx": 14,
              "end_idx": 20
            },
            {
              "entity_id": "T96",
              "entity": "预混胰素类似物",
              "entity_type": "Drug",
              "start_idx": 22,
              "end_idx": 29
            },
            {
              "entity_id": "T97",
              "entity": "预混人胰岛素",
              "entity_type": "Drug",
              "start_idx": 31,
              "end_idx": 37
            },
            {
              "entity_id": "T98",
              "entity": "预混胰岛素类似物",
              "entity_type": "Drug",
              "start_idx": 39,
              "end_idx": 47
            }
          ],
          "relations": []
        },
        {
          "sentence_id": "2",
          "sentence": "2.1.3 起始剂量每日1次起始剂量一般为0.2IU/(kg·d)，",
          "start_idx": 100,
          "end_idx": 134,
          "entities": [
            {
              "entity_id": "T99",
              "entity": "每日1次",
              "entity_type": "Frequency",
              "start_idx": 10,
              "end_idx": 14
            },
            {
              "entity_id": "T100",
              "entity": "0.2IU/(kg·d)",
              "entity_type": "Amount",
              "start_idx": 21,
              "end_idx": 33
            }
          ],
          "relations": []
        }
      ]
    },
    {
      "paragraph_id": "15",
      "paragraph": "晚餐前注射，根据患者情况作适当调整。",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "晚餐前注射，根据患者情况作适当调整。",
          "start_idx": 0,
          "end_idx": 18,
          "entities": [
            {
              "entity_id": "T101",
              "entity": "晚餐前注射",
              "entity_type": "Method",
              "start_idx": 0,
              "end_idx": 5
            }
          ],
          "relations": []
        }
      ]
    },
    {
      "paragraph_id": "16",
      "paragraph": "2.1.4 注意事项",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "2.1.4 注意事项",
          "start_idx": 0,
          "end_idx": 10,
          "entities": [],
          "relations": []
        }
      ]
    },
    {
      "paragraph_id": "17",
      "paragraph": "(1)如果HbA1c或空腹血糖仍不达标，则可改为每日2次治疗方案，可参考1-2-3次方案；",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "(1)如果HbA1c或空腹血糖仍不达标，则可改为每日2次治疗方案，可参考1-2-3次方案；",
          "start_idx": 0,
          "end_idx": 45,
          "entities": [
            {
              "entity_id": "T102",
              "entity": "HbA1c",
              "entity_type": "Test_items",
              "start_idx": 5,
              "end_idx": 10
            },
            {
              "entity_id": "T103",
              "entity": "空腹血糖",
              "entity_type": "Test_items",
              "start_idx": 11,
              "end_idx": 15
            },
            {
              "entity_id": "T104",
              "entity": "不达标",
              "entity_type": "Test_Value",
              "start_idx": 16,
              "end_idx": 19
            },
            {
              "entity_id": "T105",
              "entity": "每日2次",
              "entity_type": "Frequency",
              "start_idx": 24,
              "end_idx": 28
            }
          ],
          "relations": []
        }
      ]
    },
    {
      "paragraph_id": "18",
      "paragraph": "(2)预混人胰岛素应在餐前30min皮下注射，预混胰岛素类似物可在餐前即刻注射或餐后立即注射；",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "(2)预混人胰岛素应在餐前30min皮下注射，预混胰岛素类似物可在餐前即刻注射或餐后立即注射；",
          "start_idx": 0,
          "end_idx": 47,
          "entities": [
            {
              "entity_id": "T106",
              "entity": "预混人胰岛素",
              "entity_type": "Drug",
              "start_idx": 3,
              "end_idx": 9
            },
            {
              "entity_id": "T107",
              "entity": "餐前30min皮下注射",
              "entity_type": "Method",
              "start_idx": 11,
              "end_idx": 22
            },
            {
              "entity_id": "T108",
              "entity": "预混胰岛素类似物",
              "entity_type": "Drug",
              "start_idx": 23,
              "end_idx": 31
            },
            {
              "entity_id": "T109",
              "entity": "餐前即刻注射",
              "entity_type": "Method",
              "start_idx": 33,
              "end_idx": 39
            },
            {
              "entity_id": "T110",
              "entity": "餐后立即注射",
              "entity_type": "Method",
              "start_idx": 40,
              "end_idx": 46
            }
          ],
          "relations": [
            {
              "relation_type": "Method_Drug",
              "relation_id": "R18",
              "head_entity_id": "T107",
              "tail_entity_id": "T106"
            },
            {
              "relation_type": "Method_Drug",
              "relation_id": "R19",
              "head_entity_id": "T109",
              "tail_entity_id": "T108"
            },
            {
              "relation_type": "Method_Drug",
              "relation_id": "R20",
              "head_entity_id": "T110",
              "tail_entity_id": "T108"
            }
          ]
        }
      ]
    },
    {
      "paragraph_id": "19",
      "paragraph": "(3)在预混胰岛素选择方面，临床医生应注意根据患者具体情况决定，中预混胰岛素主要针对餐后血糖升高明显的患者；",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "(3)在预混胰岛素选择方面，临床医生应注意根据患者具体情况决定，中预混胰岛素主要针对餐后血糖升高明显的患者；",
          "start_idx": 0,
          "end_idx": 54,
          "entities": [
            {
              "entity_id": "T111",
              "entity": "预混胰岛素",
              "entity_type": "Drug",
              "start_idx": 4,
              "end_idx": 9
            },
            {
              "entity_id": "T112",
              "entity": "预混胰岛素",
              "entity_type": "Drug",
              "start_idx": 33,
              "end_idx": 38
            },
            {
              "entity_id": "T113",
              "entity": "餐后血糖",
              "entity_type": "Test_items",
              "start_idx": 42,
              "end_idx": 46
            },
            {
              "entity_id": "T114",
              "entity": "升高",
              "entity_type": "Test_Value",
              "start_idx": 46,
              "end_idx": 48
            }
          ],
          "relations": []
        }
      ]
    },
    {
      "paragraph_id": "20",
      "paragraph": "(4)可根据患者具体情况调整口服降糖药。",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "(4)可根据患者具体情况调整口服降糖药。",
          "start_idx": 0,
          "end_idx": 20,
          "entities": [
            {
              "entity_id": "T115",
              "entity": "口服",
              "entity_type": "Method",
              "start_idx": 14,
              "end_idx": 16
            }
          ],
          "relations": []
        }
      ]
    },
    {
      "paragraph_id": "21",
      "paragraph": "2.2 每日2次方案",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "2.2 每日2次方案",
          "start_idx": 0,
          "end_idx": 10,
          "entities": [
            {
              "entity_id": "T116",
              "entity": "每日2次",
              "entity_type": "Frequency",
              "start_idx": 4,
              "end_idx": 8
            }
          ],
          "relations": []
        }
      ]
    },
    {
      "paragraph_id": "22",
      "paragraph": "2.2.1 适用人群",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "2.2.1 适用人群",
          "start_idx": 0,
          "end_idx": 10,
          "entities": [],
          "relations": []
        }
      ]
    },
    {
      "paragraph_id": "23",
      "paragraph": "(1)新诊断T2DM患者，HbA1c≥9.0%同时合并明显临床症状；",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "(1)新诊断T2DM患者，HbA1c≥9.0%同时合并明显临床症状；",
          "start_idx": 0,
          "end_idx": 34,
          "entities": [
            {
              "entity_id": "T117",
              "entity": "T2DM",
              "entity_type": "Disease",
              "start_idx": 6,
              "end_idx": 10
            },
            {
              "entity_id": "T118",
              "entity": "T2",
              "entity_type": "Class",
              "start_idx": 6,
              "end_idx": 8
            },
            {
              "entity_id": "T119",
              "entity": "HbA1c",
              "entity_type": "Test_items",
              "start_idx": 13,
              "end_idx": 18
            },
            {
              "entity_id": "T120",
              "entity": "≥9.0%",
              "entity_type": "Test_Value",
              "start_idx": 18,
              "end_idx": 23
            }
          ],
          "relations": [
            {
              "relation_type": "Class_Disease",
              "relation_id": "R21",
              "head_entity_id": "T118",
              "tail_entity_id": "T117"
            },
            {
              "relation_type": "Test_items_Disease",
              "relation_id": "R22",
              "head_entity_id": "T119",
              "tail_entity_id": "T117"
            }
          ]
        }
      ]
    },
    {
      "paragraph_id": "24",
      "paragraph": "(2)生活方式干预及两种或两种以上口服降糖药最大有效剂量治疗后HbA1c≥9.0%的患者；",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "(2)生活方式干预及两种或两种以上口服降糖药最大有效剂量治疗后HbA1c≥9.0%的患者；",
          "start_idx": 0,
          "end_idx": 45,
          "entities": [
            {
              "entity_id": "T121",
              "entity": "生活方式干预",
              "entity_type": "Treatment",
              "start_idx": 3,
              "end_idx": 9
            },
            {
              "entity_id": "T122",
              "entity": "口服",
              "entity_type": "Method",
              "start_idx": 17,
              "end_idx": 19
            },
            {
              "entity_id": "T123",
              "entity": "HbA1c",
              "entity_type": "Test_items",
              "start_idx": 31,
              "end_idx": 36
            },
            {
              "entity_id": "T124",
              "entity": "≥9.0%",
              "entity_type": "Test_Value",
              "start_idx": 36,
              "end_idx": 41
            }
          ],
          "relations": []
        }
      ]
    },
    {
      "paragraph_id": "25",
      "paragraph": "(3)口服降糖药物联合基础胰岛素治疗以后，HbA1c≥7%，而空腹血糖已达标的患者。",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "(3)口服降糖药物联合基础胰岛素治疗以后，HbA1c≥7%，而空腹血糖已达标的患者。",
          "start_idx": 0,
          "end_idx": 42,
          "entities": [
            {
              "entity_id": "T125",
              "entity": "口服",
              "entity_type": "Method",
              "start_idx": 3,
              "end_idx": 5
            },
            {
              "entity_id": "T126",
              "entity": "胰岛素",
              "entity_type": "Drug",
              "start_idx": 13,
              "end_idx": 16
            },
            {
              "entity_id": "T127",
              "entity": "HbA1c",
              "entity_type": "Test_items",
              "start_idx": 21,
              "end_idx": 26
            },
            {
              "entity_id": "T128",
              "entity": "≥7%",
              "entity_type": "Test_Value",
              "start_idx": 26,
              "end_idx": 29
            },
            {
              "entity_id": "T129",
              "entity": "空腹血糖",
              "entity_type": "Test_items",
              "start_idx": 31,
              "end_idx": 35
            },
            {
              "entity_id": "T130",
              "entity": "达标",
              "entity_type": "Test_Value",
              "start_idx": 36,
              "end_idx": 38
            }
          ],
          "relations": []
        }
      ]
    },
    {
      "paragraph_id": "26",
      "paragraph": "2.2.2 预混胰岛素选择低预混人胰岛素、低预混胰岛素类似物、中预混人胰岛素、中预混胰岛素类似物。",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "2.2.2 预混胰岛素选择低预混人胰岛素、低预混胰岛素类似物、中预混人胰岛素、中预混胰岛素类似物。",
          "start_idx": 0,
          "end_idx": 49,
          "entities": [
            {
              "entity_id": "T131",
              "entity": "预混胰岛素",
              "entity_type": "Drug",
              "start_idx": 6,
              "end_idx": 11
            },
            {
              "entity_id": "T132",
              "entity": "预混人胰岛素",
              "entity_type": "Drug",
              "start_idx": 14,
              "end_idx": 20
            },
            {
              "entity_id": "T133",
              "entity": "预混胰岛素类似物",
              "entity_type": "Drug",
              "start_idx": 22,
              "end_idx": 30
            },
            {
              "entity_id": "T134",
              "entity": "预混人胰岛素",
              "entity_type": "Drug",
              "start_idx": 32,
              "end_idx": 38
            },
            {
              "entity_id": "T135",
              "entity": "预混胰岛素类似物",
              "entity_type": "Drug",
              "start_idx": 40,
              "end_idx": 48
            }
          ],
          "relations": []
        }
      ]
    },
    {
      "paragraph_id": "27",
      "paragraph": "2.2.3 起始剂量对于(1)、(2)情况，一般为0.2~0.4IU/(kg·d)或10~12IU/d，按1：1分配到早餐前和晚餐前；对于(3)情况，一般以基础胰岛素与预混胰岛素以1：1.3的比例进行剂量转换，按1：1分配到早餐前和晚餐前。临床医生一定要根据患者具体情况决定预混胰岛素类别、日总剂量和早晚餐前剂量的分配比例。",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "2.2.3 起始剂量对于(1)、(2)情况，一般为0.2~0.4IU/(kg·d)或10~12IU/d，按1：1分配到早餐前和晚餐前；对于(3)情况，一般以基础胰岛素与预混胰岛素以1：1.3的比例进行剂量转换，按1：1分配到早餐前和晚餐前。",
          "start_idx": 0,
          "end_idx": 120,
          "entities": [
            {
              "entity_id": "T136",
              "entity": "0.2~0.4IU/(kg·d)",
              "entity_type": "Amount",
              "start_idx": 25,
              "end_idx": 41
            },
            {
              "entity_id": "T137",
              "entity": "10~12IU/d",
              "entity_type": "Amount",
              "start_idx": 42,
              "end_idx": 51
            },
            {
              "entity_id": "T138",
              "entity": "胰岛素",
              "entity_type": "Drug",
              "start_idx": 80,
              "end_idx": 83
            },
            {
              "entity_id": "T139",
              "entity": "预混胰岛素",
              "entity_type": "Drug",
              "start_idx": 84,
              "end_idx": 89
            }
          ],
          "relations": []
        },
        {
          "sentence_id": "1",
          "sentence": "临床医生一定要根据患者具体情况决定预混胰岛素类别、日总剂量和早晚餐前剂量的分配比例。",
          "start_idx": 120,
          "end_idx": 162,
          "entities": [
            {
              "entity_id": "T140",
              "entity": "预混胰岛素",
              "entity_type": "Drug",
              "start_idx": 17,
              "end_idx": 22
            }
          ],
          "relations": []
        }
      ]
    },
    {
      "paragraph_id": "28",
      "paragraph": "2.2.4 注意事项",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "2.2.4 注意事项",
          "start_idx": 0,
          "end_idx": 10,
          "entities": [],
          "relations": []
        }
      ]
    },
    {
      "paragraph_id": "29",
      "paragraph": "(1)采用预混胰岛素每日2次治疗方案时，不建议同时使用胰岛素促泌剂(主要不良反应与胰岛素一致，为低血糖和体重增加)；",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "(1)采用预混胰岛素每日2次治疗方案时，不建议同时使用胰岛素促泌剂(主要不良反应与胰岛素一致，为低血糖和体重增加)；",
          "start_idx": 0,
          "end_idx": 58,
          "entities": [
            {
              "entity_id": "T141",
              "entity": "预混胰岛素",
              "entity_type": "Drug",
              "start_idx": 5,
              "end_idx": 10
            },
            {
              "entity_id": "T142",
              "entity": "每日2次",
              "entity_type": "Frequency",
              "start_idx": 10,
              "end_idx": 14
            },
            {
              "entity_id": "T143",
              "entity": "胰岛素促泌剂",
              "entity_type": "Drug",
              "start_idx": 27,
              "end_idx": 33
            },
            {
              "entity_id": "T144",
              "entity": "胰岛素",
              "entity_type": "Drug",
              "start_idx": 41,
              "end_idx": 44
            },
            {
              "entity_id": "T145",
              "entity": "低血糖",
              "entity_type": "ADE",
              "start_idx": 48,
              "end_idx": 51
            },
            {
              "entity_id": "T146",
              "entity": "体重增加",
              "entity_type": "ADE",
              "start_idx": 52,
              "end_idx": 56
            }
          ],
          "relations": [
            {
              "relation_type": "Frequency_Drug",
              "relation_id": "R23",
              "head_entity_id": "T142",
              "tail_entity_id": "T141"
            },
            {
              "relation_type": "ADE_Drug",
              "relation_id": "R24",
              "head_entity_id": "T145",
              "tail_entity_id": "T143"
            },
            {
              "relation_type": "ADE_Drug",
              "relation_id": "R25",
              "head_entity_id": "T146",
              "tail_entity_id": "T143"
            },
            {
              "relation_type": "ADE_Drug",
              "relation_id": "R26",
              "head_entity_id": "T145",
              "tail_entity_id": "T144"
            },
            {
              "relation_type": "ADE_Drug",
              "relation_id": "R27",
              "head_entity_id": "T146",
              "tail_entity_id": "T144"
            }
          ]
        }
      ]
    },
    {
      "paragraph_id": "30",
      "paragraph": "(2)可继续使用二甲双胍或α-糖苷酶抑制剂，视患者个体情况决定是否停用TZD类药物；",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "(2)可继续使用二甲双胍或α-糖苷酶抑制剂，视患者个体情况决定是否停用TZD类药物；",
          "start_idx": 0,
          "end_idx": 42,
          "entities": [
            {
              "entity_id": "T147",
              "entity": "二甲双胍",
              "entity_type": "Drug",
              "start_idx": 8,
              "end_idx": 12
            },
            {
              "entity_id": "T148",
              "entity": "α-糖苷酶抑制剂",
              "entity_type": "Drug",
              "start_idx": 13,
              "end_idx": 21
            },
            {
              "entity_id": "T149",
              "entity": "TZD类药物",
              "entity_type": "Drug",
              "start_idx": 35,
              "end_idx": 41
            }
          ],
          "relations": []
        }
      ]
    },
    {
      "paragraph_id": "31",
      "paragraph": "(3)按时、定量进餐及规律运动，预混人胰岛素应在早、晚餐前30min皮下注射，预混胰岛素类似物",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "(3)按时、定量进餐及规律运动，预混人胰岛素应在早、晚餐前30min皮下注射，预混胰岛素类似物",
          "start_idx": 0,
          "end_idx": 47,
          "entities": [
            {
              "entity_id": "T150",
              "entity": "按时、定量进餐",
              "entity_type": "Treatment",
              "start_idx": 3,
              "end_idx": 10
            },
            {
              "entity_id": "T151",
              "entity": "规律运动",
              "entity_type": "Treatment",
              "start_idx": 11,
              "end_idx": 15
            },
            {
              "entity_id": "T152",
              "entity": "预混人胰岛素",
              "entity_type": "Drug",
              "start_idx": 16,
              "end_idx": 22
            },
            {
              "entity_id": "T153",
              "entity": "早、晚餐前30min皮下注射",
              "entity_type": "Method",
              "start_idx": 24,
              "end_idx": 38
            },
            {
              "entity_id": "T154",
              "entity": "预混胰岛素类似物",
              "entity_type": "Drug",
              "start_idx": 39,
              "end_idx": 47
            }
          ],
          "relations": [
            {
              "relation_type": "Method_Drug",
              "relation_id": "R28",
              "head_entity_id": "T153",
              "tail_entity_id": "T152"
            }
          ]
        }
      ]
    },
    {
      "paragraph_id": "32",
      "paragraph": "可在餐前即刻注射或餐后立即注射；",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "可在餐前即刻注射或餐后立即注射；",
          "start_idx": 0,
          "end_idx": 16,
          "entities": [
            {
              "entity_id": "T155",
              "entity": "餐前即刻注射",
              "entity_type": "Method",
              "start_idx": 2,
              "end_idx": 8
            },
            {
              "entity_id": "T156",
              "entity": "餐后立即注射",
              "entity_type": "Method",
              "start_idx": 9,
              "end_idx": 15
            }
          ],
          "relations": []
        }
      ]
    },
    {
      "paragraph_id": "33",
      "paragraph": "(4)中预混胰岛素主要针对餐后血糖升高明显或者血糖波动较大的患者(如口服降糖药失效后，早餐后血糖≥13.5mmol/L或早餐前后血糖波动≥4.4mmol/L)，以及饮食中碳水化合物比例较高的患者；",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "(4)中预混胰岛素主要针对餐后血糖升高明显或者血糖波动较大的患者(如口服降糖药失效后，早餐后血糖≥13.5mmol/L或早餐前后血糖波动≥4.4mmol/L)，以及饮食中碳水化合物比例较高的患者；",
          "start_idx": 0,
          "end_idx": 98,
          "entities": [
            {
              "entity_id": "T157",
              "entity": "预混胰岛素",
              "entity_type": "Drug",
              "start_idx": 4,
              "end_idx": 9
            },
            {
              "entity_id": "T158",
              "entity": "餐后血糖",
              "entity_type": "Test_items",
              "start_idx": 13,
              "end_idx": 17
            },
            {
              "entity_id": "T159",
              "entity": "升高",
              "entity_type": "Test_Value",
              "start_idx": 17,
              "end_idx": 19
            },
            {
              "entity_id": "T160",
              "entity": "血糖",
              "entity_type": "Test_items",
              "start_idx": 23,
              "end_idx": 25
            },
            {
              "entity_id": "T161",
              "entity": "波动较大",
              "entity_type": "Test_Value",
              "start_idx": 25,
              "end_idx": 29
            },
            {
              "entity_id": "T162",
              "entity": "口服",
              "entity_type": "Method",
              "start_idx": 34,
              "end_idx": 36
            },
            {
              "entity_id": "T163",
              "entity": "早餐后血糖",
              "entity_type": "Test_items",
              "start_idx": 43,
              "end_idx": 48
            },
            {
              "entity_id": "T164",
              "entity": "≥13.5mmol/L",
              "entity_type": "Test_Value",
              "start_idx": 48,
              "end_idx": 59
            },
            {
              "entity_id": "T165",
              "entity": "波动≥4.4mmol/L",
              "entity_type": "Test_Value",
              "start_idx": 66,
              "end_idx": 78
            },
            {
              "entity_id": "T166",
              "entity": "早餐前后血糖",
              "entity_type": "Test_items",
              "start_idx": 60,
              "end_idx": 66
            }
          ],
          "relations": []
        }
      ]
    },
    {
      "paragraph_id": "34",
      "paragraph": "(5)若低预混人胰岛素每日2次治疗的患者餐后血糖≥11.1mmol/L，临床医生可依据具体情况考虑等剂量改为低预混胰岛素类似物或中预混胰岛素类似物。",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "(5)若低预混人胰岛素每日2次治疗的患者餐后血糖≥11.1mmol/L，临床医生可依据具体情况考虑等剂量改为低预混胰岛素类似物或中预混胰岛素类似物。",
          "start_idx": 0,
          "end_idx": 74,
          "entities": [
            {
              "entity_id": "T167",
              "entity": "预混人胰岛素",
              "entity_type": "Drug",
              "start_idx": 5,
              "end_idx": 11
            },
            {
              "entity_id": "T168",
              "entity": "每日2次",
              "entity_type": "Frequency",
              "start_idx": 11,
              "end_idx": 15
            },
            {
              "entity_id": "T169",
              "entity": "餐后血糖",
              "entity_type": "Test_items",
              "start_idx": 20,
              "end_idx": 24
            },
            {
              "entity_id": "T170",
              "entity": "≥11.1mmol/L",
              "entity_type": "Test_Value",
              "start_idx": 24,
              "end_idx": 35
            },
            {
              "entity_id": "T171",
              "entity": "预混胰岛素类似物",
              "entity_type": "Drug",
              "start_idx": 55,
              "end_idx": 63
            },
            {
              "entity_id": "T172",
              "entity": "预混胰岛素类似物",
              "entity_type": "Drug",
              "start_idx": 65,
              "end_idx": 73
            }
          ],
          "relations": [
            {
              "relation_type": "Frequency_Drug",
              "relation_id": "R29",
              "head_entity_id": "T168",
              "tail_entity_id": "T167"
            }
          ]
        }
      ]
    },
    {
      "paragraph_id": "35",
      "paragraph": "2.3 每日3次方案",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "2.3 每日3次方案",
          "start_idx": 0,
          "end_idx": 10,
          "entities": [
            {
              "entity_id": "T173",
              "entity": "每日3次",
              "entity_type": "Frequency",
              "start_idx": 4,
              "end_idx": 8
            }
          ],
          "relations": []
        }
      ]
    },
    {
      "paragraph_id": "36",
      "paragraph": "2.3.1 适用人群 ",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "2.3.1 适用人群 ",
          "start_idx": 0,
          "end_idx": 11,
          "entities": [],
          "relations": []
        }
      ]
    },
    {
      "paragraph_id": "37",
      "paragraph": "(1)预混胰岛素每日2次治疗后HbA1c≥7.0%的患者；",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "(1)预混胰岛素每日2次治疗后HbA1c≥7.0%的患者；",
          "start_idx": 0,
          "end_idx": 29,
          "entities": [
            {
              "entity_id": "T174",
              "entity": "预混胰岛素",
              "entity_type": "Drug",
              "start_idx": 3,
              "end_idx": 8
            },
            {
              "entity_id": "T175",
              "entity": "每日2次",
              "entity_type": "Frequency",
              "start_idx": 8,
              "end_idx": 12
            },
            {
              "entity_id": "T176",
              "entity": "HbA1c",
              "entity_type": "Test_items",
              "start_idx": 15,
              "end_idx": 20
            },
            {
              "entity_id": "T177",
              "entity": "≥7.0%",
              "entity_type": "Test_Value",
              "start_idx": 20,
              "end_idx": 25
            }
          ],
          "relations": [
            {
              "relation_type": "Frequency_Drug",
              "relation_id": "R30",
              "head_entity_id": "T175",
              "tail_entity_id": "T174"
            }
          ]
        }
      ]
    },
    {
      "paragraph_id": "38",
      "paragraph": "(2)?血糖控制不达标，需要基础+餐时胰岛素强化治疗，但不愿意接受该治疗方案的患者。",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "(2)?血糖控制不达标，需要基础+餐时胰岛素强化治疗，但不愿意接受该治疗方案的患者。",
          "start_idx": 0,
          "end_idx": 42,
          "entities": [
            {
              "entity_id": "T178",
              "entity": "血糖",
              "entity_type": "Test_items",
              "start_idx": 4,
              "end_idx": 6
            },
            {
              "entity_id": "T179",
              "entity": "控制不达标",
              "entity_type": "Test_Value",
              "start_idx": 6,
              "end_idx": 11
            },
            {
              "entity_id": "T180",
              "entity": "胰岛素",
              "entity_type": "Drug",
              "start_idx": 19,
              "end_idx": 22
            }
          ],
          "relations": []
        }
      ]
    },
    {
      "paragraph_id": "39",
      "paragraph": "2.3.2 预混胰岛素选择低预混胰岛素类似物、中预混胰岛素类似物。",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "2.3.2 预混胰岛素选择低预混胰岛素类似物、中预混胰岛素类似物。",
          "start_idx": 0,
          "end_idx": 33,
          "entities": [
            {
              "entity_id": "T181",
              "entity": "预混胰岛素",
              "entity_type": "Drug",
              "start_idx": 6,
              "end_idx": 11
            },
            {
              "entity_id": "T182",
              "entity": "预混胰岛素类似物",
              "entity_type": "Drug",
              "start_idx": 14,
              "end_idx": 22
            },
            {
              "entity_id": "T183",
              "entity": "预混胰岛素类似物",
              "entity_type": "Drug",
              "start_idx": 24,
              "end_idx": 32
            }
          ],
          "relations": []
        }
      ]
    },
    {
      "paragraph_id": "40",
      "paragraph": "2.3.3 起始剂量对于(1)情况，早晚餐前等剂量转换，午餐前加2~4IU或每天胰岛素总量的10%，并可能需要减少早餐前的剂量2~4IU；对于(2)情况，临床医生根据具体情况决定。",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "2.3.3 起始剂量对于(1)情况，早晚餐前等剂量转换，午餐前加2~4IU或每天胰岛素总量的10%，并可能需要减少早餐前的剂量2~4IU；对于(2)情况，临床医生根据具体情况决定。",
          "start_idx": 0,
          "end_idx": 90,
          "entities": [
            {
              "entity_id": "T184",
              "entity": "2~4IU",
              "entity_type": "Amount",
              "start_idx": 32,
              "end_idx": 37
            },
            {
              "entity_id": "T185",
              "entity": "2~4IU",
              "entity_type": "Amount",
              "start_idx": 63,
              "end_idx": 68
            },
            {
              "entity_id": "T186",
              "entity": "胰岛素",
              "entity_type": "Drug",
              "start_idx": 40,
              "end_idx": 43
            }
          ],
          "relations": [
            {
              "relation_type": "Amount_Drug",
              "relation_id": "R31",
              "head_entity_id": "T184",
              "tail_entity_id": "T186"
            },
            {
              "relation_type": "Amount_Drug",
              "relation_id": "R32",
              "head_entity_id": "T185",
              "tail_entity_id": "T186"
            }
          ]
        }
      ]
    },
    {
      "paragraph_id": "41",
      "paragraph": "2.3.4 注意事项",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "2.3.4 注意事项",
          "start_idx": 0,
          "end_idx": 10,
          "entities": [],
          "relations": []
        }
      ]
    },
    {
      "paragraph_id": "42",
      "paragraph": "(1)如果预混胰岛素从每日2次增加至每日3次时，建议将预混人胰岛素改为预混胰岛素类似物；",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "(1)如果预混胰岛素从每日2次增加至每日3次时，建议将预混人胰岛素改为预混胰岛素类似物；",
          "start_idx": 0,
          "end_idx": 44,
          "entities": [
            {
              "entity_id": "T187",
              "entity": "预混胰岛素",
              "entity_type": "Drug",
              "start_idx": 5,
              "end_idx": 10
            },
            {
              "entity_id": "T188",
              "entity": "每日2次",
              "entity_type": "Frequency",
              "start_idx": 11,
              "end_idx": 15
            },
            {
              "entity_id": "T189",
              "entity": "每日3次",
              "entity_type": "Frequency",
              "start_idx": 18,
              "end_idx": 22
            },
            {
              "entity_id": "T190",
              "entity": "预混人胰岛素",
              "entity_type": "Drug",
              "start_idx": 27,
              "end_idx": 33
            },
            {
              "entity_id": "T191",
              "entity": "预混胰岛素类似物",
              "entity_type": "Drug",
              "start_idx": 35,
              "end_idx": 43
            }
          ],
          "relations": [
            {
              "relation_type": "Frequency_Drug",
              "relation_id": "R33",
              "head_entity_id": "T188",
              "tail_entity_id": "T187"
            },
            {
              "relation_type": "Frequency_Drug",
              "relation_id": "R34",
              "head_entity_id": "T189",
              "tail_entity_id": "T187"
            }
          ]
        }
      ]
    },
    {
      "paragraph_id": "43",
      "paragraph": "(2)若低预混胰岛素每日2次治疗，HbA1c≥7.0%，早餐后血糖<10.0mmol/L，可考虑调整为低预混胰岛素类似物每日3次；若早餐后血糖≥10.0mmol/L的患者，则可考虑调整为中预混胰岛素类似物3次治疗；",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "(2)若低预混胰岛素每日2次治疗，HbA1c≥7.0%，早餐后血糖<10.0mmol/L，可考虑调整为低预混胰岛素类似物每日3次；若早餐后血糖≥10.0mmol/L的患者，则可考虑调整为中预混胰岛素类似物3次治疗；",
          "start_idx": 0,
          "end_idx": 107,
          "entities": [
            {
              "entity_id": "T192",
              "entity": "预混胰岛素",
              "entity_type": "Drug",
              "start_idx": 5,
              "end_idx": 10
            },
            {
              "entity_id": "T193",
              "entity": "每日2次",
              "entity_type": "Frequency",
              "start_idx": 10,
              "end_idx": 14
            },
            {
              "entity_id": "T194",
              "entity": "HbA1c",
              "entity_type": "Test_items",
              "start_idx": 17,
              "end_idx": 22
            },
            {
              "entity_id": "T195",
              "entity": "≥7.0%",
              "entity_type": "Test_Value",
              "start_idx": 22,
              "end_idx": 27
            },
            {
              "entity_id": "T196",
              "entity": "早餐后血糖",
              "entity_type": "Test_items",
              "start_idx": 28,
              "end_idx": 33
            },
            {
              "entity_id": "T197",
              "entity": "<10.0mmol/L",
              "entity_type": "Test_Value",
              "start_idx": 33,
              "end_idx": 44
            },
            {
              "entity_id": "T198",
              "entity": "预混胰岛素类似物",
              "entity_type": "Drug",
              "start_idx": 52,
              "end_idx": 60
            },
            {
              "entity_id": "T199",
              "entity": "每日3次",
              "entity_type": "Frequency",
              "start_idx": 60,
              "end_idx": 64
            },
            {
              "entity_id": "T200",
              "entity": "早餐后血糖",
              "entity_type": "Test_items",
              "start_idx": 66,
              "end_idx": 71
            },
            {
              "entity_id": "T201",
              "entity": "≥10.0mmol/L",
              "entity_type": "Test_Value",
              "start_idx": 71,
              "end_idx": 82
            },
            {
              "entity_id": "T202",
              "entity": "预混胰岛素类似物",
              "entity_type": "Drug",
              "start_idx": 94,
              "end_idx": 102
            }
          ],
          "relations": [
            {
              "relation_type": "Frequency_Drug",
              "relation_id": "R35",
              "head_entity_id": "T193",
              "tail_entity_id": "T192"
            },
            {
              "relation_type": "Frequency_Drug",
              "relation_id": "R36",
              "head_entity_id": "T199",
              "tail_entity_id": "T198"
            }
          ]
        }
      ]
    },
    {
      "paragraph_id": "44",
      "paragraph": "(3)预混胰岛素类似物可在餐前即刻注射或餐后立即注射；",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "(3)预混胰岛素类似物可在餐前即刻注射或餐后立即注射；",
          "start_idx": 0,
          "end_idx": 27,
          "entities": [
            {
              "entity_id": "T203",
              "entity": "预混胰岛素类似物",
              "entity_type": "Drug",
              "start_idx": 3,
              "end_idx": 11
            },
            {
              "entity_id": "T204",
              "entity": "餐前即刻注射",
              "entity_type": "Method",
              "start_idx": 13,
              "end_idx": 19
            },
            {
              "entity_id": "T205",
              "entity": "餐后立即注射",
              "entity_type": "Method",
              "start_idx": 20,
              "end_idx": 26
            }
          ],
          "relations": [
            {
              "relation_type": "Method_Drug",
              "relation_id": "R37",
              "head_entity_id": "T204",
              "tail_entity_id": "T203"
            },
            {
              "relation_type": "Method_Drug",
              "relation_id": "R38",
              "head_entity_id": "T205",
              "tail_entity_id": "T203"
            }
          ]
        }
      ]
    },
    {
      "paragraph_id": "45",
      "paragraph": "(4)对于中预混胰岛素类似物每日3次治疗患者，如果餐后血糖控制好而空腹血糖>6mmol/L时，可考虑将晚餐前调整为低预混胰岛素类似物。",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "(4)对于中预混胰岛素类似物每日3次治疗患者，如果餐后血糖控制好而空腹血糖>6mmol/L时，可考虑将晚餐前调整为低预混胰岛素类似物。",
          "start_idx": 0,
          "end_idx": 67,
          "entities": [
            {
              "entity_id": "T206",
              "entity": "预混胰岛素类似物",
              "entity_type": "Drug",
              "start_idx": 6,
              "end_idx": 14
            },
            {
              "entity_id": "T207",
              "entity": "预混胰岛素类似物",
              "entity_type": "Drug",
              "start_idx": 58,
              "end_idx": 66
            },
            {
              "entity_id": "T208",
              "entity": "每日3次",
              "entity_type": "Frequency",
              "start_idx": 14,
              "end_idx": 18
            },
            {
              "entity_id": "T209",
              "entity": "餐后血糖",
              "entity_type": "Test_items",
              "start_idx": 25,
              "end_idx": 29
            },
            {
              "entity_id": "T210",
              "entity": "控制好",
              "entity_type": "Test_Value",
              "start_idx": 29,
              "end_idx": 32
            },
            {
              "entity_id": "T211",
              "entity": "空腹血糖",
              "entity_type": "Test_items",
              "start_idx": 33,
              "end_idx": 37
            },
            {
              "entity_id": "T212",
              "entity": ">6mmol/L",
              "entity_type": "Test_Value",
              "start_idx": 37,
              "end_idx": 45
            }
          ],
          "relations": [
            {
              "relation_type": "Frequency_Drug",
              "relation_id": "R39",
              "head_entity_id": "T208",
              "tail_entity_id": "T206"
            }
          ]
        }
      ]
    },
    {
      "paragraph_id": "47",
      "paragraph": "2.4.1 适用人群生活方式干预及两种或两种以上口服降糖药最大有效剂量治疗后HbA1c≥7.0%的患者。",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "2.4.1 适用人群生活方式干预及两种或两种以上口服降糖药最大有效剂量治疗后HbA1c≥7.0%的患者。",
          "start_idx": 0,
          "end_idx": 52,
          "entities": [
            {
              "entity_id": "T213",
              "entity": "生活方式干预",
              "entity_type": "Treatment",
              "start_idx": 10,
              "end_idx": 16
            },
            {
              "entity_id": "T214",
              "entity": "口服",
              "entity_type": "Method",
              "start_idx": 24,
              "end_idx": 26
            },
            {
              "entity_id": "T215",
              "entity": "HbA1c",
              "entity_type": "Test_items",
              "start_idx": 38,
              "end_idx": 43
            },
            {
              "entity_id": "T216",
              "entity": "≥7.0%",
              "entity_type": "Test_Value",
              "start_idx": 43,
              "end_idx": 48
            }
          ],
          "relations": []
        }
      ]
    },
    {
      "paragraph_id": "48",
      "paragraph": "2.4.2 预混胰岛素选择低预混胰岛素类似物、中预混胰岛素类似物。",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "2.4.2 预混胰岛素选择低预混胰岛素类似物、中预混胰岛素类似物。",
          "start_idx": 0,
          "end_idx": 33,
          "entities": [
            {
              "entity_id": "T217",
              "entity": "预混胰岛素",
              "entity_type": "Drug",
              "start_idx": 6,
              "end_idx": 11
            },
            {
              "entity_id": "T218",
              "entity": "预混胰岛素类似物",
              "entity_type": "Drug",
              "start_idx": 14,
              "end_idx": 22
            },
            {
              "entity_id": "T219",
              "entity": "预混胰岛素类似物",
              "entity_type": "Drug",
              "start_idx": 24,
              "end_idx": 32
            }
          ],
          "relations": []
        }
      ]
    },
    {
      "paragraph_id": "49",
      "paragraph": "2.4.3 起始剂量预混胰岛素类似物每日1次起始剂量一般为10~12IU，晚餐前注射，根据早餐前血糖调整剂量；如果治疗后HbA1c或餐前血糖不达标，则早餐前加用预混胰岛素类似物3~6IU，根据晚餐前和空腹血糖调整早餐前和晚餐前剂量；如果治疗后HbA1c或午餐后血糖不达标，则午餐前加用预混胰岛素类似物3IU或将早餐前剂量按1：1分配到早、午餐前，根据午餐后或晚餐前血糖调整午餐前剂量。",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "2.4.3 起始剂量预混胰岛素类似物每日1次起始剂量一般为10~12IU，晚餐前注射，根据早餐前血糖调整剂量；如果治疗后HbA1c或餐前血糖不达标，则早餐前加用预混胰岛素类似物3~6IU，根据晚餐前和空腹血糖调整早餐前和晚餐前剂量；如果治疗后HbA1c或午餐后血糖不达标，则午餐前加用预混胰岛素类似物3IU或将早餐前剂量按1：1分配到早、午餐前，根据午餐后或晚餐前血糖调整午餐前剂量。",
          "start_idx": 0,
          "end_idx": 192,
          "entities": [
            {
              "entity_id": "T220",
              "entity": "预混胰岛素类似物",
              "entity_type": "Drug",
              "start_idx": 10,
              "end_idx": 18
            },
            {
              "entity_id": "T221",
              "entity": "预混胰岛素类似物",
              "entity_type": "Drug",
              "start_idx": 80,
              "end_idx": 88
            },
            {
              "entity_id": "T222",
              "entity": "预混胰岛素类似物",
              "entity_type": "Drug",
              "start_idx": 142,
              "end_idx": 150
            },
            {
              "entity_id": "T223",
              "entity": "每日1次",
              "entity_type": "Frequency",
              "start_idx": 18,
              "end_idx": 22
            },
            {
              "entity_id": "T224",
              "entity": "10~12IU",
              "entity_type": "Amount",
              "start_idx": 29,
              "end_idx": 36
            },
            {
              "entity_id": "T225",
              "entity": "晚餐前注射",
              "entity_type": "Method",
              "start_idx": 37,
              "end_idx": 42
            },
            {
              "entity_id": "T226",
              "entity": "早餐前血糖",
              "entity_type": "Test_items",
              "start_idx": 45,
              "end_idx": 50
            },
            {
              "entity_id": "T227",
              "entity": "HbA1c",
              "entity_type": "Test_items",
              "start_idx": 60,
              "end_idx": 65
            },
            {
              "entity_id": "T228",
              "entity": "餐前血糖",
              "entity_type": "Test_items",
              "start_idx": 66,
              "end_idx": 70
            },
            {
              "entity_id": "T229",
              "entity": "不达标",
              "entity_type": "Test_Value",
              "start_idx": 70,
              "end_idx": 73
            },
            {
              "entity_id": "T230",
              "entity": "3~6IU",
              "entity_type": "Amount",
              "start_idx": 88,
              "end_idx": 93
            },
            {
              "entity_id": "T231",
              "entity": "晚餐前和空腹血糖",
              "entity_type": "Test_items",
              "start_idx": 96,
              "end_idx": 104
            },
            {
              "entity_id": "T232",
              "entity": "HbA1c",
              "entity_type": "Test_items",
              "start_idx": 121,
              "end_idx": 126
            },
            {
              "entity_id": "T233",
              "entity": "午餐后血糖",
              "entity_type": "Test_items",
              "start_idx": 127,
              "end_idx": 132
            },
            {
              "entity_id": "T234",
              "entity": "不达标",
              "entity_type": "Test_Value",
              "start_idx": 132,
              "end_idx": 135
            },
            {
              "entity_id": "T235",
              "entity": "3IU",
              "entity_type": "Amount",
              "start_idx": 150,
              "end_idx": 153
            },
            {
              "entity_id": "T236",
              "entity": "午餐后或晚餐前血糖",
              "entity_type": "Test_items",
              "start_idx": 175,
              "end_idx": 184
            }
          ],
          "relations": [
            {
              "relation_type": "Frequency_Drug",
              "relation_id": "R40",
              "head_entity_id": "T223",
              "tail_entity_id": "T220"
            },
            {
              "relation_type": "Amount_Drug",
              "relation_id": "R41",
              "head_entity_id": "T224",
              "tail_entity_id": "T220"
            },
            {
              "relation_type": "Method_Drug",
              "relation_id": "R42",
              "head_entity_id": "T225",
              "tail_entity_id": "T220"
            },
            {
              "relation_type": "Amount_Drug",
              "relation_id": "R43",
              "head_entity_id": "T230",
              "tail_entity_id": "T221"
            },
            {
              "relation_type": "Amount_Drug",
              "relation_id": "R44",
              "head_entity_id": "T235",
              "tail_entity_id": "T222"
            }
          ]
        }
      ]
    },
    {
      "paragraph_id": "50",
      "paragraph": "2.4.4 注意事项",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "2.4.4 注意事项",
          "start_idx": 0,
          "end_idx": 10,
          "entities": [],
          "relations": []
        }
      ]
    },
    {
      "paragraph_id": "51",
      "paragraph": "(1)一般在口服降糖药治疗的基础上加用预混胰岛素类似物每日1次治疗，临床医生也可根据患者具体情况调整口服降糖药；",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "(1)一般在口服降糖药治疗的基础上加用预混胰岛素类似物每日1次治疗，临床医生也可根据患者具体情况调整口服降糖药；",
          "start_idx": 0,
          "end_idx": 56,
          "entities": [
            {
              "entity_id": "T237",
              "entity": "口服",
              "entity_type": "Method",
              "start_idx": 6,
              "end_idx": 8
            },
            {
              "entity_id": "T238",
              "entity": "预混胰岛素类似物",
              "entity_type": "Drug",
              "start_idx": 19,
              "end_idx": 27
            },
            {
              "entity_id": "T239",
              "entity": "每日1次",
              "entity_type": "Frequency",
              "start_idx": 27,
              "end_idx": 31
            },
            {
              "entity_id": "T240",
              "entity": "口服",
              "entity_type": "Method",
              "start_idx": 50,
              "end_idx": 52
            }
          ],
          "relations": [
            {
              "relation_type": "Frequency_Drug",
              "relation_id": "R45",
              "head_entity_id": "T239",
              "tail_entity_id": "T238"
            }
          ]
        }
      ]
    },
    {
      "paragraph_id": "52",
      "paragraph": "(2)当调整为预混胰岛素类似物每日2次或每日3次治疗时，不建议同时使用胰岛素促泌剂(主要不良反应与胰岛素一致，为低血糖和体重增加)；",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "(2)当调整为预混胰岛素类似物每日2次或每日3次治疗时，不建议同时使用胰岛素促泌剂(主要不良反应与胰岛素一致，为低血糖和体重增加)；",
          "start_idx": 0,
          "end_idx": 66,
          "entities": [
            {
              "entity_id": "T241",
              "entity": "预混胰岛素类似物",
              "entity_type": "Drug",
              "start_idx": 7,
              "end_idx": 15
            },
            {
              "entity_id": "T242",
              "entity": "每日2次",
              "entity_type": "Frequency",
              "start_idx": 15,
              "end_idx": 19
            },
            {
              "entity_id": "T243",
              "entity": "每日3次",
              "entity_type": "Frequency",
              "start_idx": 20,
              "end_idx": 24
            },
            {
              "entity_id": "T244",
              "entity": "胰岛素促泌剂",
              "entity_type": "Drug",
              "start_idx": 35,
              "end_idx": 41
            },
            {
              "entity_id": "T245",
              "entity": "胰岛素",
              "entity_type": "Drug",
              "start_idx": 49,
              "end_idx": 52
            },
            {
              "entity_id": "T246",
              "entity": "低血糖",
              "entity_type": "ADE",
              "start_idx": 56,
              "end_idx": 59
            },
            {
              "entity_id": "T247",
              "entity": "体重增加",
              "entity_type": "ADE",
              "start_idx": 60,
              "end_idx": 64
            }
          ],
          "relations": [
            {
              "relation_type": "Frequency_Drug",
              "relation_id": "R46",
              "head_entity_id": "T242",
              "tail_entity_id": "T241"
            },
            {
              "relation_type": "Frequency_Drug",
              "relation_id": "R47",
              "head_entity_id": "T243",
              "tail_entity_id": "T241"
            },
            {
              "relation_type": "ADE_Drug",
              "relation_id": "R48",
              "head_entity_id": "T246",
              "tail_entity_id": "T244"
            },
            {
              "relation_type": "ADE_Drug",
              "relation_id": "R49",
              "head_entity_id": "T247",
              "tail_entity_id": "T244"
            },
            {
              "relation_type": "ADE_Drug",
              "relation_id": "R50",
              "head_entity_id": "T246",
              "tail_entity_id": "T245"
            },
            {
              "relation_type": "ADE_Drug",
              "relation_id": "R51",
              "head_entity_id": "T247",
              "tail_entity_id": "T245"
            }
          ]
        }
      ]
    },
    {
      "paragraph_id": "53",
      "paragraph": "(3)可继续使用二甲双胍或α-糖苷酶抑制剂，视患者个体情况决定是否停用TZD类药物；",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "(3)可继续使用二甲双胍或α-糖苷酶抑制剂，视患者个体情况决定是否停用TZD类药物；",
          "start_idx": 0,
          "end_idx": 42,
          "entities": [
            {
              "entity_id": "T248",
              "entity": "二甲双胍",
              "entity_type": "Drug",
              "start_idx": 8,
              "end_idx": 12
            },
            {
              "entity_id": "T249",
              "entity": "α-糖苷酶抑制剂",
              "entity_type": "Drug",
              "start_idx": 13,
              "end_idx": 21
            },
            {
              "entity_id": "T250",
              "entity": "TZD类药物",
              "entity_type": "Drug",
              "start_idx": 35,
              "end_idx": 41
            }
          ],
          "relations": []
        }
      ]
    },
    {
      "paragraph_id": "54",
      "paragraph": "(4)中预混胰岛素类似物主要针对餐后血糖升高明显的患者；",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "(4)中预混胰岛素类似物主要针对餐后血糖升高明显的患者；",
          "start_idx": 0,
          "end_idx": 28,
          "entities": [
            {
              "entity_id": "T251",
              "entity": "预混胰岛素类似物",
              "entity_type": "Drug",
              "start_idx": 4,
              "end_idx": 12
            },
            {
              "entity_id": "T252",
              "entity": "餐后血糖",
              "entity_type": "Test_items",
              "start_idx": 16,
              "end_idx": 20
            },
            {
              "entity_id": "T253",
              "entity": "升高",
              "entity_type": "Test_Value",
              "start_idx": 20,
              "end_idx": 22
            }
          ],
          "relations": []
        }
      ]
    },
    {
      "paragraph_id": "55",
      "paragraph": "(5)预混胰岛素类似物应在餐前即刻注射或餐后立即注射。",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "(5)预混胰岛素类似物应在餐前即刻注射或餐后立即注射。",
          "start_idx": 0,
          "end_idx": 27,
          "entities": [
            {
              "entity_id": "T254",
              "entity": "预混胰岛素类似物",
              "entity_type": "Drug",
              "start_idx": 3,
              "end_idx": 11
            },
            {
              "entity_id": "T255",
              "entity": "餐前即刻注射",
              "entity_type": "Method",
              "start_idx": 13,
              "end_idx": 19
            },
            {
              "entity_id": "T256",
              "entity": "餐后立即注射",
              "entity_type": "Method",
              "start_idx": 20,
              "end_idx": 26
            }
          ],
          "relations": [
            {
              "relation_type": "Method_Drug",
              "relation_id": "R52",
              "head_entity_id": "T255",
              "tail_entity_id": "T254"
            },
            {
              "relation_type": "Method_Drug",
              "relation_id": "R53",
              "head_entity_id": "T256",
              "tail_entity_id": "T254"
            }
          ]
        }
      ]
    },
    {
      "paragraph_id": "56",
      "paragraph": "3 自我血糖监测",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "3 自我血糖监测",
          "start_idx": 0,
          "end_idx": 8,
          "entities": [
            {
              "entity_id": "T257",
              "entity": "自我血糖监测",
              "entity_type": "Test_items",
              "start_idx": 2,
              "end_idx": 8
            }
          ],
          "relations": []
        }
      ]
    },
    {
      "paragraph_id": "57",
      "paragraph": "自我血糖监测(self-monitoring of blood glucose，SMBG)是糖尿病管理中的重要组成部分，其结果有助于评估降糖治疗的效果并指导治疗方案的调整。可根据不同的胰岛素治疗方案制定个体化的SMBG方案。",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "自我血糖监测(self-monitoring of blood glucose，SMBG)是糖尿病管理中的重要组成部分，其结果有助于评估降糖治疗的效果并指导治疗方案的调整。",
          "start_idx": 0,
          "end_idx": 86,
          "entities": [
            {
              "entity_id": "T258",
              "entity": "糖尿病",
              "entity_type": "Disease",
              "start_idx": 46,
              "end_idx": 49
            },
            {
              "entity_id": "T260",
              "entity": "自我血糖监测(self-monitoring of blood glucose，SMBG)",
              "entity_type": "Test_items",
              "start_idx": 0,
              "end_idx": 45
            }
          ],
          "relations": [
            {
              "relation_type": "Test_items_Disease",
              "relation_id": "R54",
              "head_entity_id": "T260",
              "tail_entity_id": "T258"
            }
          ]
        },
        {
          "sentence_id": "1",
          "sentence": "可根据不同的胰岛素治疗方案制定个体化的SMBG方案。",
          "start_idx": 86,
          "end_idx": 112,
          "entities": [
            {
              "entity_id": "T259",
              "entity": "胰岛素",
              "entity_type": "Drug",
              "start_idx": 6,
              "end_idx": 9
            },
            {
              "entity_id": "T261",
              "entity": "SMBG",
              "entity_type": "Test_items",
              "start_idx": 19,
              "end_idx": 23
            }
          ],
          "relations": []
        }
      ]
    },
    {
      "paragraph_id": "58",
      "paragraph": "3.1 每日1次预混胰岛素类似物治疗的SMBG方案每日1次预混胰岛素类似物治疗的患者在血糖达标前每周监测3天空腹、晚餐后和睡前血糖，每2周复诊1次，复诊前1天加测3个时间点血糖；在血糖达标后每周监测3次血糖，即空腹、晚餐后和睡前血糖，每月复诊1次，复诊前1天加测3个时间点血糖(见表2)。",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "3.1 每日1次预混胰岛素类似物治疗的SMBG方案每日1次预混胰岛素类似物治疗的患者在血糖达标前每周监测3天空腹、晚餐后和睡前血糖，每2周复诊1次，复诊前1天加测3个时间点血糖；在血糖达标后每周监测3次血糖，即空腹、晚餐后和睡前血糖，每月复诊1次，复诊前1天加测3个时间点血糖(见表2)。",
          "start_idx": 0,
          "end_idx": 144,
          "entities": [
            {
              "entity_id": "T262",
              "entity": "每日1次",
              "entity_type": "Frequency",
              "start_idx": 4,
              "end_idx": 8
            },
            {
              "entity_id": "T263",
              "entity": "预混胰岛素类似物",
              "entity_type": "Drug",
              "start_idx": 8,
              "end_idx": 16
            },
            {
              "entity_id": "T264",
              "entity": "SMBG",
              "entity_type": "Test_items",
              "start_idx": 19,
              "end_idx": 23
            },
            {
              "entity_id": "T265",
              "entity": "每日1次",
              "entity_type": "Frequency",
              "start_idx": 25,
              "end_idx": 29
            },
            {
              "entity_id": "T266",
              "entity": "预混胰岛素类似物",
              "entity_type": "Drug",
              "start_idx": 29,
              "end_idx": 37
            },
            {
              "entity_id": "T267",
              "entity": "血糖",
              "entity_type": "Test_items",
              "start_idx": 43,
              "end_idx": 45
            },
            {
              "entity_id": "T268",
              "entity": "达标",
              "entity_type": "Test_Value",
              "start_idx": 45,
              "end_idx": 47
            },
            {
              "entity_id": "T269",
              "entity": "空腹、晚餐后和睡前血糖",
              "entity_type": "Test_items",
              "start_idx": 54,
              "end_idx": 65
            },
            {
              "entity_id": "T270",
              "entity": "血糖",
              "entity_type": "Test_items",
              "start_idx": 86,
              "end_idx": 88
            },
            {
              "entity_id": "T271",
              "entity": "血糖",
              "entity_type": "Test_items",
              "start_idx": 90,
              "end_idx": 92
            },
            {
              "entity_id": "T272",
              "entity": "达标",
              "entity_type": "Test_Value",
              "start_idx": 92,
              "end_idx": 94
            },
            {
              "entity_id": "T273",
              "entity": "血糖",
              "entity_type": "Test_items",
              "start_idx": 101,
              "end_idx": 103
            },
            {
              "entity_id": "T274",
              "entity": "空腹、晚餐后和睡前血糖",
              "entity_type": "Test_items",
              "start_idx": 105,
              "end_idx": 116
            },
            {
              "entity_id": "T275",
              "entity": "血糖",
              "entity_type": "Test_items",
              "start_idx": 136,
              "end_idx": 138
            }
          ],
          "relations": [
            {
              "relation_type": "Frequency_Drug",
              "relation_id": "R55",
              "head_entity_id": "T262",
              "tail_entity_id": "T263"
            },
            {
              "relation_type": "Frequency_Drug",
              "relation_id": "R56",
              "head_entity_id": "T265",
              "tail_entity_id": "T266"
            }
          ]
        }
      ]
    },
    {
      "paragraph_id": "59",
      "paragraph": "3.2 每日2次预混胰岛素(包括预混人胰岛素和预混胰岛素类似物)治疗的SMBG方案每日2次预混胰岛素治疗的患者在血糖达标前每周监测3天空腹和晚餐前血糖，每2周复诊1次，复诊前1天加测5个时间点血糖；在血糖达标后每周监测3次血糖，即空腹、晚餐前和晚餐后血糖，每月复诊1次，复诊前1天加测5个时间点血糖(见表3)。",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "3.2 每日2次预混胰岛素(包括预混人胰岛素和预混胰岛素类似物)治疗的SMBG方案每日2次预混胰岛素治疗的患者在血糖达标前每周监测3天空腹和晚餐前血糖，每2周复诊1次，复诊前1天加测5个时间点血糖；在血糖达标后每周监测3次血糖，即空腹、晚餐前和晚餐后血糖，每月复诊1次，复诊前1天加测5个时间点血糖(见表3)。",
          "start_idx": 0,
          "end_idx": 155,
          "entities": [
            {
              "entity_id": "T276",
              "entity": "每日2次",
              "entity_type": "Frequency",
              "start_idx": 4,
              "end_idx": 8
            },
            {
              "entity_id": "T277",
              "entity": "预混胰岛素",
              "entity_type": "Drug",
              "start_idx": 8,
              "end_idx": 13
            },
            {
              "entity_id": "T278",
              "entity": "预混人胰岛素",
              "entity_type": "Drug",
              "start_idx": 16,
              "end_idx": 22
            },
            {
              "entity_id": "T279",
              "entity": "预混胰岛素类似物",
              "entity_type": "Drug",
              "start_idx": 23,
              "end_idx": 31
            },
            {
              "entity_id": "T280",
              "entity": "SMBG",
              "entity_type": "Test_items",
              "start_idx": 35,
              "end_idx": 39
            },
            {
              "entity_id": "T281",
              "entity": "每日2次",
              "entity_type": "Frequency",
              "start_idx": 41,
              "end_idx": 45
            },
            {
              "entity_id": "T282",
              "entity": "预混胰岛素",
              "entity_type": "Drug",
              "start_idx": 45,
              "end_idx": 50
            },
            {
              "entity_id": "T283",
              "entity": "血糖",
              "entity_type": "Test_items",
              "start_idx": 56,
              "end_idx": 58
            },
            {
              "entity_id": "T284",
              "entity": "达标",
              "entity_type": "Test_Value",
              "start_idx": 58,
              "end_idx": 60
            },
            {
              "entity_id": "T285",
              "entity": "空腹和晚餐前血糖",
              "entity_type": "Test_items",
              "start_idx": 67,
              "end_idx": 75
            },
            {
              "entity_id": "T286",
              "entity": "血糖",
              "entity_type": "Test_items",
              "start_idx": 96,
              "end_idx": 98
            },
            {
              "entity_id": "T287",
              "entity": "血糖",
              "entity_type": "Test_items",
              "start_idx": 100,
              "end_idx": 102
            },
            {
              "entity_id": "T288",
              "entity": "达标",
              "entity_type": "Test_Value",
              "start_idx": 102,
              "end_idx": 104
            },
            {
              "entity_id": "T289",
              "entity": "血糖",
              "entity_type": "Test_items",
              "start_idx": 111,
              "end_idx": 113
            },
            {
              "entity_id": "T290",
              "entity": "空腹、晚餐前和晚餐后血糖",
              "entity_type": "Test_items",
              "start_idx": 115,
              "end_idx": 127
            },
            {
              "entity_id": "T291",
              "entity": "血糖",
              "entity_type": "Test_items",
              "start_idx": 147,
              "end_idx": 149
            }
          ],
          "relations": [
            {
              "relation_type": "Frequency_Drug",
              "relation_id": "R57",
              "head_entity_id": "T276",
              "tail_entity_id": "T277"
            },
            {
              "relation_type": "Frequency_Drug",
              "relation_id": "R58",
              "head_entity_id": "T281",
              "tail_entity_id": "T282"
            }
          ]
        }
      ]
    },
    {
      "paragraph_id": "60",
      "paragraph": "3.3 每日3次预混胰岛素类似物治疗的SMBG方案每日3次预混胰岛素类似物治疗的开始阶段应每天监5~7个时间点血糖，包括空腹、三餐前后、睡前，血糖达标后每日监测2~4个时间点血糖(见表4)。3.4 注意事项在胰岛素治疗期间，如有低血糖表现时需随时监测血糖；如出现不可解释的空腹高血糖或夜间低血糖时，应监测夜间血糖(如3am血糖)。",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "3.3 每日3次预混胰岛素类似物治疗的SMBG方案每日3次预混胰岛素类似物治疗的开始阶段应每天监5~7个时间点血糖，包括空腹、三餐前后、睡前，血糖达标后每日监测2~4个时间点血糖(见表4)。3.4 注意事项在胰岛素治疗期间，如有低血糖表现时需随时监测血糖；如出现不可解释的空腹高血糖或夜间低血糖时，应监测夜间血糖(如3am血糖)。",
          "start_idx": 0,
          "end_idx": 165,
          "entities": [
            {
              "entity_id": "T292",
              "entity": "每日3次",
              "entity_type": "Frequency",
              "start_idx": 4,
              "end_idx": 8
            },
            {
              "entity_id": "T293",
              "entity": "预混胰岛素类似物",
              "entity_type": "Drug",
              "start_idx": 8,
              "end_idx": 16
            },
            {
              "entity_id": "T294",
              "entity": "SMBG",
              "entity_type": "Test_items",
              "start_idx": 19,
              "end_idx": 23
            },
            {
              "entity_id": "T295",
              "entity": "每日3次",
              "entity_type": "Frequency",
              "start_idx": 25,
              "end_idx": 29
            },
            {
              "entity_id": "T296",
              "entity": "预混胰岛素类似物",
              "entity_type": "Drug",
              "start_idx": 29,
              "end_idx": 37
            },
            {
              "entity_id": "T297",
              "entity": "血糖",
              "entity_type": "Test_items",
              "start_idx": 55,
              "end_idx": 57
            },
            {
              "entity_id": "T298",
              "entity": "血糖",
              "entity_type": "Test_items",
              "start_idx": 71,
              "end_idx": 73
            },
            {
              "entity_id": "T299",
              "entity": "达标",
              "entity_type": "Test_Value",
              "start_idx": 73,
              "end_idx": 75
            },
            {
              "entity_id": "T300",
              "entity": "血糖",
              "entity_type": "Test_items",
              "start_idx": 87,
              "end_idx": 89
            },
            {
              "entity_id": "T301",
              "entity": "胰岛素",
              "entity_type": "Drug",
              "start_idx": 104,
              "end_idx": 107
            },
            {
              "entity_id": "T302",
              "entity": "低血糖",
              "entity_type": "ADE",
              "start_idx": 114,
              "end_idx": 117
            },
            {
              "entity_id": "T303",
              "entity": "监测血糖",
              "entity_type": "Test_items",
              "start_idx": 123,
              "end_idx": 127
            },
            {
              "entity_id": "T304",
              "entity": "高血糖",
              "entity_type": "ADE",
              "start_idx": 138,
              "end_idx": 141
            },
            {
              "entity_id": "T305",
              "entity": "低血糖",
              "entity_type": "ADE",
              "start_idx": 144,
              "end_idx": 147
            },
            {
              "entity_id": "T306",
              "entity": "监测夜间血糖",
              "entity_type": "Test_items",
              "start_idx": 150,
              "end_idx": 156
            },
            {
              "entity_id": "T307",
              "entity": "3am血糖",
              "entity_type": "Test_items",
              "start_idx": 158,
              "end_idx": 163
            }
          ],
          "relations": [
            {
              "relation_type": "Frequency_Drug",
              "relation_id": "R59",
              "head_entity_id": "T292",
              "tail_entity_id": "T293"
            },
            {
              "relation_type": "Frequency_Drug",
              "relation_id": "R60",
              "head_entity_id": "T295",
              "tail_entity_id": "T296"
            },
            {
              "relation_type": "ADE_Drug",
              "relation_id": "R61",
              "head_entity_id": "T302",
              "tail_entity_id": "T301"
            },
            {
              "relation_type": "ADE_Drug",
              "relation_id": "R62",
              "head_entity_id": "T304",
              "tail_entity_id": "T301"
            },
            {
              "relation_type": "ADE_Drug",
              "relation_id": "R63",
              "head_entity_id": "T305",
              "tail_entity_id": "T301"
            }
          ]
        }
      ]
    },
    {
      "paragraph_id": "61",
      "paragraph": "4 预混胰岛素剂量调整方法",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "4 预混胰岛素剂量调整方法",
          "start_idx": 0,
          "end_idx": 13,
          "entities": [
            {
              "entity_id": "T308",
              "entity": "预混胰岛素",
              "entity_type": "Drug",
              "start_idx": 2,
              "end_idx": 7
            }
          ],
          "relations": []
        }
      ]
    },
    {
      "paragraph_id": "62",
      "paragraph": "临床医生应根据患者具体情况设定血糖控制目标。在胰岛素治疗期间，结合血糖监测结果，适时调整治疗方案和胰岛素剂量，以取得良好的血糖控制。对于不同的预混胰岛素治疗方案，其剂量调整方法有所不同，可参考每日2次预混胰岛素治疗方案(见表5)和1-2-3次预混胰岛素类似物治疗方案的剂量调整方法(见表6)，每3~5天调整1次，每次调整1~4IU，直至血糖达标。",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "临床医生应根据患者具体情况设定血糖控制目标。",
          "start_idx": 0,
          "end_idx": 22,
          "entities": [
            {
              "entity_id": "T309",
              "entity": "血糖",
              "entity_type": "Test_items",
              "start_idx": 15,
              "end_idx": 17
            }
          ],
          "relations": []
        },
        {
          "sentence_id": "1",
          "sentence": "在胰岛素治疗期间，结合血糖监测结果，适时调整治疗方案和胰岛素剂量，以取得良好的血糖控制。对于不同的预混胰岛素治疗方案，其剂量调整方法有所不同，可参考每日2次预混胰岛素治疗方案(见表5)和1-2-3次预混胰岛素类似物治疗方案的剂量调整方法(见表6)，每3~5天调整1次，每次调整1~4IU，直至血糖达标。",
          "start_idx": 22,
          "end_idx": 173,
          "entities": [
            {
              "entity_id": "T310",
              "entity": "胰岛素",
              "entity_type": "Drug",
              "start_idx": 1,
              "end_idx": 4
            },
            {
              "entity_id": "T311",
              "entity": "血糖监测",
              "entity_type": "Test_items",
              "start_idx": 11,
              "end_idx": 15
            },
            {
              "entity_id": "T312",
              "entity": "胰岛素",
              "entity_type": "Drug",
              "start_idx": 27,
              "end_idx": 30
            },
            {
              "entity_id": "T313",
              "entity": "血糖",
              "entity_type": "Test_items",
              "start_idx": 39,
              "end_idx": 41
            },
            {
              "entity_id": "T314",
              "entity": "预混胰岛素",
              "entity_type": "Drug",
              "start_idx": 49,
              "end_idx": 54
            },
            {
              "entity_id": "T315",
              "entity": "每日2次",
              "entity_type": "Frequency",
              "start_idx": 74,
              "end_idx": 78
            },
            {
              "entity_id": "T316",
              "entity": "预混胰岛素",
              "entity_type": "Drug",
              "start_idx": 78,
              "end_idx": 83
            },
            {
              "entity_id": "T317",
              "entity": "预混胰岛素类似物",
              "entity_type": "Drug",
              "start_idx": 99,
              "end_idx": 107
            },
            {
              "entity_id": "T318",
              "entity": "1~4IU",
              "entity_type": "Amount",
              "start_idx": 138,
              "end_idx": 143
            },
            {
              "entity_id": "T319",
              "entity": "血糖",
              "entity_type": "Test_items",
              "start_idx": 146,
              "end_idx": 148
            },
            {
              "entity_id": "T320",
              "entity": "达标",
              "entity_type": "Test_Value",
              "start_idx": 148,
              "end_idx": 150
            }
          ],
          "relations": [
            {
              "relation_type": "Frequency_Drug",
              "relation_id": "R64",
              "head_entity_id": "T315",
              "tail_entity_id": "T316"
            },
            {
              "relation_type": "Amount_Drug",
              "relation_id": "R65",
              "head_entity_id": "T318",
              "tail_entity_id": "T316"
            },
            {
              "relation_type": "Amount_Drug",
              "relation_id": "R66",
              "head_entity_id": "T318",
              "tail_entity_id": "T317"
            }
          ]
        }
      ]
    },
    {
      "paragraph_id": "63",
      "paragraph": "5 需要注意的情况",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "5 需要注意的情况",
          "start_idx": 0,
          "end_idx": 9,
          "entities": [],
          "relations": []
        }
      ]
    },
    {
      "paragraph_id": "64",
      "paragraph": "T2DM患者的血糖控制目标因患者的年龄、合并症、并发症等不同而异，临床医生应注意结合患者病情、经济等各方面的因素综合考虑，选择适合患者的治疗方案。对已合并心脑血管疾病或其他危险因素的T2DM患者，在胰岛素治疗治疗时，应当采取稳妥、安全的降糖治疗措施和目标值，尽量避免低血糖的发生。",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "T2DM患者的血糖控制目标因患者的年龄、合并症、并发症等不同而异，临床医生应注意结合患者病情、经济等各方面的因素综合考虑，选择适合患者的治疗方案。对已合并心脑血管疾病或其他危险因素的T2DM患者，在胰岛素治疗治疗时，应当采取稳妥、安全的降糖治疗措施和目标值，尽量避免低血糖的发生。",
          "start_idx": 0,
          "end_idx": 140,
          "entities": [
            {
              "entity_id": "T321",
              "entity": "T2DM",
              "entity_type": "Disease",
              "start_idx": 0,
              "end_idx": 4
            },
            {
              "entity_id": "T322",
              "entity": "T2",
              "entity_type": "Class",
              "start_idx": 0,
              "end_idx": 2
            },
            {
              "entity_id": "T323",
              "entity": "血糖",
              "entity_type": "Test_items",
              "start_idx": 7,
              "end_idx": 9
            },
            {
              "entity_id": "T324",
              "entity": "心脑血管疾病",
              "entity_type": "Disease",
              "start_idx": 77,
              "end_idx": 83
            },
            {
              "entity_id": "T325",
              "entity": "心脑血管",
              "entity_type": "Anatomy",
              "start_idx": 77,
              "end_idx": 81
            },
            {
              "entity_id": "T326",
              "entity": "T2DM",
              "entity_type": "Disease",
              "start_idx": 91,
              "end_idx": 95
            },
            {
              "entity_id": "T327",
              "entity": "T2",
              "entity_type": "Class",
              "start_idx": 91,
              "end_idx": 93
            },
            {
              "entity_id": "T328",
              "entity": "胰岛素",
              "entity_type": "Drug",
              "start_idx": 99,
              "end_idx": 102
            },
            {
              "entity_id": "T329",
              "entity": "低血糖",
              "entity_type": "ADE",
              "start_idx": 133,
              "end_idx": 136
            }
          ],
          "relations": [
            {
              "relation_type": "Class_Disease",
              "relation_id": "R67",
              "head_entity_id": "T322",
              "tail_entity_id": "T321"
            },
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R68",
              "head_entity_id": "T325",
              "tail_entity_id": "T324"
            },
            {
              "relation_type": "Class_Disease",
              "relation_id": "R69",
              "head_entity_id": "T327",
              "tail_entity_id": "T326"
            },
            {
              "relation_type": "ADE_Drug",
              "relation_id": "R70",
              "head_entity_id": "T329",
              "tail_entity_id": "T328"
            }
          ]
        }
      ]
    },
    {
      "paragraph_id": "65",
      "paragraph": "6 小结",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "6 小结",
          "start_idx": 0,
          "end_idx": 4,
          "entities": [],
          "relations": []
        }
      ]
    },
    {
      "paragraph_id": "66",
      "paragraph": "预混胰岛素能同时提供基础及餐时胰岛素，方案简便、易操作，在中国糖尿病患者中应用广泛。临床医生要根据患者的具体情况综合考虑，包括生活方式、方案的简便程度，长期依从性，血糖监测及低血糖发生等多种因素，制定个体化的胰岛素治疗方案。预混胰岛素基本治疗路线(见图1)的制定借鉴了国内外诸多临床研究的经验，为实际应用提供指导和帮助。",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "预混胰岛素能同时提供基础及餐时胰岛素，方案简便、易操作，在中国糖尿病患者中应用广泛。临床医生要根据患者的具体情况综合考虑，包括生活方式、方案的简便程度，长期依从性，血糖监测及低血糖发生等多种因素，制定个体化的胰岛素治疗方案。",
          "start_idx": 0,
          "end_idx": 112,
          "entities": [
            {
              "entity_id": "T330",
              "entity": "预混胰岛素",
              "entity_type": "Drug",
              "start_idx": 0,
              "end_idx": 5
            },
            {
              "entity_id": "T331",
              "entity": "糖尿病",
              "entity_type": "Disease",
              "start_idx": 31,
              "end_idx": 34
            },
            {
              "entity_id": "T332",
              "entity": "血糖监测",
              "entity_type": "Test_items",
              "start_idx": 82,
              "end_idx": 86
            },
            {
              "entity_id": "T333",
              "entity": "低血糖",
              "entity_type": "ADE",
              "start_idx": 87,
              "end_idx": 90
            },
            {
              "entity_id": "T334",
              "entity": "胰岛素",
              "entity_type": "Drug",
              "start_idx": 104,
              "end_idx": 107
            },
            {
              "entity_id": "T336",
              "entity": "胰岛素",
              "entity_type": "Drug",
              "start_idx": 15,
              "end_idx": 18
            }
          ],
          "relations": [
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R71",
              "head_entity_id": "T330",
              "tail_entity_id": "T331"
            },
            {
              "relation_type": "Test_items_Disease",
              "relation_id": "R72",
              "head_entity_id": "T332",
              "tail_entity_id": "T331"
            },
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R73",
              "head_entity_id": "T336",
              "tail_entity_id": "T331"
            },
            {
              "relation_type": "ADE_Drug",
              "relation_id": "R74",
              "head_entity_id": "T333",
              "tail_entity_id": "T334"
            }
          ]
        },
        {
          "sentence_id": "1",
          "sentence": "预混胰岛素基本治疗路线(见图1)的制定借鉴了国内外诸多临床研究的经验，为实际应用提供指导和帮助。",
          "start_idx": 112,
          "end_idx": 160,
          "entities": [
            {
              "entity_id": "T335",
              "entity": "预混胰岛素",
              "entity_type": "Drug",
              "start_idx": 0,
              "end_idx": 5
            }
          ],
          "relations": []
        }
      ]
    },
    {
      "paragraph_id": "46",
      "paragraph": "2.4 1-2-3次方案1-2-3次方案是指，对于采用生活方式干预及两种或两种以上口服降糖药最大有效剂量治疗血糖仍不达标(HbA1c≥7.0%)的患者，起始每日1次预混胰岛素类似物注射，血糖控制仍不达标时，可逐渐增加到每日2次、每日3次的方案。",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "2.4 1-2-3次方案1-2-3次方案是指，对于采用生活方式干预及两种或两种以上口服降糖药最大有效剂量治疗血糖仍不达标(HbA1c≥7.0%)的患者，起始每日1次预混胰岛素类似物注射，血糖控制仍不达标时，可逐渐增加到每日2次、每日3次的方案。",
          "start_idx": 0,
          "end_idx": 122,
          "entities": [
            {
              "entity_id": "T337",
              "entity": "生活方式干预",
              "entity_type": "Treatment",
              "start_idx": 27,
              "end_idx": 33
            },
            {
              "entity_id": "T338",
              "entity": "口服",
              "entity_type": "Method",
              "start_idx": 41,
              "end_idx": 43
            },
            {
              "entity_id": "T339",
              "entity": "血糖",
              "entity_type": "Test_items",
              "start_idx": 54,
              "end_idx": 56
            },
            {
              "entity_id": "T340",
              "entity": "仍不达标",
              "entity_type": "Test_Value",
              "start_idx": 56,
              "end_idx": 60
            },
            {
              "entity_id": "T341",
              "entity": "HbA1c",
              "entity_type": "Test_items",
              "start_idx": 61,
              "end_idx": 66
            },
            {
              "entity_id": "T342",
              "entity": "≥7.0%",
              "entity_type": "Test_Value",
              "start_idx": 66,
              "end_idx": 71
            },
            {
              "entity_id": "T343",
              "entity": "每日1次",
              "entity_type": "Frequency",
              "start_idx": 78,
              "end_idx": 82
            },
            {
              "entity_id": "T344",
              "entity": "预混胰岛素类似物",
              "entity_type": "Drug",
              "start_idx": 82,
              "end_idx": 90
            },
            {
              "entity_id": "T345",
              "entity": "注射",
              "entity_type": "Method",
              "start_idx": 90,
              "end_idx": 92
            },
            {
              "entity_id": "T346",
              "entity": "血糖",
              "entity_type": "Test_items",
              "start_idx": 93,
              "end_idx": 95
            },
            {
              "entity_id": "T347",
              "entity": "控制仍不达标",
              "entity_type": "Test_Value",
              "start_idx": 95,
              "end_idx": 101
            },
            {
              "entity_id": "T348",
              "entity": "每日2次",
              "entity_type": "Frequency",
              "start_idx": 109,
              "end_idx": 113
            },
            {
              "entity_id": "T349",
              "entity": "每日3次",
              "entity_type": "Frequency",
              "start_idx": 114,
              "end_idx": 118
            }
          ],
          "relations": [
            {
              "relation_type": "Frequency_Drug",
              "relation_id": "R75",
              "head_entity_id": "T343",
              "tail_entity_id": "T344"
            },
            {
              "relation_type": "Frequency_Drug",
              "relation_id": "R76",
              "head_entity_id": "T348",
              "tail_entity_id": "T344"
            },
            {
              "relation_type": "Frequency_Drug",
              "relation_id": "R77",
              "head_entity_id": "T349",
              "tail_entity_id": "T344"
            },
            {
              "relation_type": "Method_Drug",
              "relation_id": "R78",
              "head_entity_id": "T345",
              "tail_entity_id": "T344"
            }
          ]
        }
      ]
    }
  ]
}